Hodnocení zhoršené mobility při ústavě kohorty chronické nemoci (EVALMOB)
Chronic illness is a public health issue and mobility loss is frequent in this population. Among its' multiple physical and psychological consequences, increased mortality and cardiovascular morbidity seem the main concern. Therefore, the exploration of locomotor deficiencies, physical capacities and metabolism of patients with chronic illnesses constitutes a major challenge both for the treatment of causal pathologies, as well as for evaluating the impact of therapeutic interventions, the benefit of which will be an improvement in physical capacities and ultimately mobility. In view of the hypothesis of an increase in the prevalence of mobility disorders in this population, this approach is part of a logic of screening and improving the effectiveness of the care of these patients with a multidisciplinary evaluation of individual risks. The EVALMOB protocol was designed in order to try to determine a standard profile of "dysmobility" in patients with chronic illness
Přehled studie
Postavení
Podmínky
Detailní popis
We propose to constitute a prospective cohort of subjects carrying chronic disease. The objective is to explore all the different components of mobility (balance, muscle force, body composition, walking ability, metabolism, etc.), to assess their impact on the functional capacity of individuals and to identify their potential interactions. Processing this data could ultimately allow the development of a model to determine a composite standard profile of "dysmobility" in patients with chronic disease.
In the present protocol, parameters will be measured on five occasions (at inclusion, at 6 months from the inclusion day, at 1,2 and 5 year(s) from the inclusion day). All tests will be performed on the same day. New assessments will be done on the same principle as the initial evaluation.
Statistical analyses will be carried out using Stata software (version 13, StataCorp, College Station, USA). Data will be described by frequencies and percentages for categorical variables and by means and standard deviation (or median and interquartile range if data are not normally distributed) for continuous variables. The normality of continuous data will be assessed graphically and using the Shapiro-Wilk test. The main analysis will consist in determining patient profiles regarding their mobility. Clustering-type approaches (supervised or not) will be proposed: k-means, vector machine support, machine learning, factor analysis. For example, factor analyses on mixed data will allow the main components of mobility to be characterized. They can be followed by an ascending hierarchical classification in order to determine homogeneous groups of patients.
These groups will be described and compared on the main criteria evaluated using standard statistical tests: chi2 test (or Fisher's exact test if applicable) for the categorical criteria and using an analysis of variance (or Kruskal-Wallis if data are not normally distributed) for continuous criteria. The main analysis will be broken down more specifically for each of the pathologies considered. In addition, the sensitivity to change will be assessed in each pathology and for each assessment criterion. The search for factors related to the evolution of the different criteria will be carried out using usual tests and mixed multivariate models (logistics for categorical / linear criteria for continuous criteria) considering the subject as a random effect, and adjusting on the time criteria (inclusion / follow-up) and the criteria highlighted in the univariate analyses and in light of the elements reported in the literature. A sensitivity analysis will be proposed in order to study the statistical nature of the missing data and to propose, if necessary, the most suitable method of imputing the data: multiple imputation, maximum bias or LOCF in the case of longitudinal data.
Typ studie
Zápis (Odhadovaný)
Fáze
- Nelze použít
Kontakty a umístění
Studijní kontakt
- Jméno: Lise Laclautre
- Telefonní číslo: 334.73.754.963
- E-mail: promo_interne_drci@chu-clermontferrand.fr
Studijní místa
-
-
-
Clermont-Ferrand, Francie, 63003
- Nábor
- Chu Clermont Ferrand
-
Vrchní vyšetřovatel:
- Frédéric Costes
-
Kontakt:
- Lise Laclautre
- E-mail: promo_interne_drci@chu-clermontferrand.fr
-
-
Kritéria účasti
Kritéria způsobilosti
Věk způsobilý ke studiu
Přijímá zdravé dobrovolníky
Pohlaví způsobilá ke studiu
Popis
Inclusion Criteria:
- Man or woman aged 18 to 90.
- Patients with chronic pathology contributing to impaired mobility.
- Volunteers who have given their written consent.
- Affiliated to French health care system (for France)
Exclusion Criteria:
- Patients suffering from progressive psychiatric pathologies (active psychosis, hallucinations, etc.) or the presence of another serious unstabilized pathology (decompensated heart failure, progressive terminal cancer, etc.).
- People with poorly controlled or unstable cardiovascular disease.
- Major osteoarticular or neurological problems completely preventing the proper performance of the various tests.
- Non-autonomous patient
- Persons under guardianship, curatorship, deprived of liberty or safeguarding justice.
- People excluded from another study.
- Pregnant or lactating women.
Studijní plán
Jak je studie koncipována?
Detaily designu
- Primární účel: Diagnostický
- Přidělení: N/A
- Intervenční model: Přiřazení jedné skupiny
- Maskování: Žádné (otevřený štítek)
Zbraně a zásahy
Skupina účastníků / Arm |
Intervence / Léčba |
|---|---|
|
Experimentální: Cohort 1
Participants will be involved in a long-term evaluation program combining, body composition measures, physical tests as well as self-administered questionnaires. Participants will be followed for 5 years with evaluations taking place at inclusion, 6 months, at 1, 2 and 5 years |
Firstly, volunteers will be invited to complete online questionnaires on a secure platform. The mobility assessment will be carried out initially (t1) and up to a maximum of 4 times (t1 to t4) as part of a day hospitalization. Questionnaires will be diverse (SF36, KOOS, HOOS, BROCKER, MNA, TAMPA, etc.) in order to assess several aspects that compose mobility. Physical evaluations will include various validated tests (isokinetic strength measure, TUG, 6MWT, Berg Balance Scale, etc.) |
Co je měření studie?
Primární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
dismobility score calculated from the results reported in secondary outcomes
Časové okno: Day 0
|
The main objective being to determine patient profiles with regard to "dysmobility", all the criteria detailed as secondary outcomes will be considered for the definition of the profiles |
Day 0
|
|
dismobility score calculated from the results reported in secondary outcomes
Časové okno: Month 6
|
The main objective being to determine patient profiles with regard to "dysmobility", all the criteria detailed as secondary outcomes will be considered for the definition of the profiles |
Month 6
|
|
dismobility score calculated from the results reported in secondary outcomes
Časové okno: Year 1
|
The main objective being to determine patient profiles with regard to "dysmobility", all the criteria detailed as secondary outcomes will be considered for the definition of the profiles |
Year 1
|
|
dismobility score calculated from the results reported in secondary outcomes
Časové okno: Year 2
|
The main objective being to determine patient profiles with regard to "dysmobility", all the criteria detailed as secondary outcomes will be considered for the definition of the profiles |
Year 2
|
|
dismobility score calculated from the results reported in secondary outcomes
Časové okno: Year 5
|
The main objective being to determine patient profiles with regard to "dysmobility", all the criteria detailed as secondary outcomes will be considered for the definition of the profiles |
Year 5
|
Sekundární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
The main objective being to determine patient profiles with regard to "dysmobility", all the criteria detailed as secondary outcomes will be considered for the definition of the profiles
Časové okno: Day 0
|
Demographics information will be obtained using a single questionnaire including questions on age, gender, qualification, personal work status, ethnicity, life and occupational events. |
Day 0
|
|
Weight (Kg).
Časové okno: Day 0
|
Weight will be measured with the medical body weight scale SECA® and according to the ISAK recommendations. |
Day 0
|
|
Weight (Kg).
Časové okno: Month 6
|
Weight will be measured with the medical body weight scale SECA® and according to the ISAK recommendations. |
Month 6
|
|
Weight (Kg).
Časové okno: Year 1
|
Weight will be measured with the medical body weight scale SECA® and according to the ISAK recommendations. |
Year 1
|
|
Weight (Kg).
Časové okno: Year 2
|
Weight will be measured with the medical body weight scale SECA® and according to the ISAK recommendations. |
Year 2
|
|
Weight (Kg).
Časové okno: Year 5
|
Weight will be measured with the medical body weight scale SECA® and according to the ISAK recommendations. |
Year 5
|
|
Height (cm).
Časové okno: Day 0
|
Height will be measured with a wall mounted tape measure and according to the ISAK recommendations |
Day 0
|
|
Height (cm).
Časové okno: Month 6
|
Height will be measured with a wall mounted tape measure and according to the ISAK recommendations |
Month 6
|
|
Height (cm).
Časové okno: Year 1
|
Height will be measured with a wall mounted tape measure and according to the ISAK recommendations |
Year 1
|
|
Height (cm).
Časové okno: Year 2
|
Height will be measured with a wall mounted tape measure and according to the ISAK recommendations |
Year 2
|
|
Height (cm).
Časové okno: Year 5
|
Height will be measured with a wall mounted tape measure and according to the ISAK recommendations |
Year 5
|
|
Body fat percentage (%).
Časové okno: Day 0
|
Body fat percentage will be measured with the Harpenden skinfold caliper by measuring skinfold thickness in four different sites (triceps; biceps, suprailiac, subscapular). |
Day 0
|
|
Body fat percentage (%).
Časové okno: Month 6
|
Body fat percentage will be measured with the Harpenden skinfold caliper by measuring skinfold thickness in four different sites (triceps; biceps, suprailiac, subscapular). |
Month 6
|
|
Body fat percentage (%).
Časové okno: Year 1
|
Body fat percentage will be measured with the Harpenden skinfold caliper by measuring skinfold thickness in four different sites (triceps; biceps, suprailiac, subscapular). |
Year 1
|
|
Body fat percentage (%).
Časové okno: Year 2
|
Body fat percentage will be measured with the Harpenden skinfold caliper by measuring skinfold thickness in four different sites (triceps; biceps, suprailiac, subscapular). |
Year 2
|
|
Body fat percentage (%).
Časové okno: Year 5
|
Body fat percentage will be measured with the Harpenden skinfold caliper by measuring skinfold thickness in four different sites (triceps; biceps, suprailiac, subscapular). |
Year 5
|
|
Waist circumference (cm).
Časové okno: Day 0
|
Waist circumference will be measured with a medical body tape measure and according to the ISAK recommendations |
Day 0
|
|
Waist circumference (cm).
Časové okno: Month 5
|
Waist circumference will be measured with a medical body tape measure and according to the ISAK recommendations |
Month 5
|
|
Waist circumference (cm).
Časové okno: Year 1
|
Waist circumference will be measured with a medical body tape measure and according to the ISAK recommendations |
Year 1
|
|
Waist circumference (cm).
Časové okno: Year 2
|
Waist circumference will be measured with a medical body tape measure and according to the ISAK recommendations |
Year 2
|
|
Waist circumference (cm).
Časové okno: Year 5
|
Waist circumference will be measured with a medical body tape measure and according to the ISAK recommendations |
Year 5
|
|
Hip circumference (cm).
Časové okno: Day 0
|
Hip circumference will be measured with a medical body tape measure and according to the ISAK recommendations. |
Day 0
|
|
Hip circumference (cm).
Časové okno: Month 6
|
Hip circumference will be measured with a medical body tape measure and according to the ISAK recommendations. |
Month 6
|
|
Hip circumference (cm).
Časové okno: Year 1
|
Hip circumference will be measured with a medical body tape measure and according to the ISAK recommendations. |
Year 1
|
|
Hip circumference (cm).
Časové okno: Year 2
|
Hip circumference will be measured with a medical body tape measure and according to the ISAK recommendations. |
Year 2
|
|
Hip circumference (cm).
Časové okno: Year 5
|
Hip circumference will be measured with a medical body tape measure and according to the ISAK recommendations. |
Year 5
|
|
Brachial circumference (cm).
Časové okno: Day 0
|
Brachial circumference will be measured with a medical body tape measure and according to the ISAK recommendations. |
Day 0
|
|
Brachial circumference (cm).
Časové okno: Month 6
|
Brachial circumference will be measured with a medical body tape measure and according to the ISAK recommendations. |
Month 6
|
|
Brachial circumference (cm).
Časové okno: Year 1
|
Brachial circumference will be measured with a medical body tape measure and according to the ISAK recommendations. |
Year 1
|
|
Brachial circumference (cm).
Časové okno: Year 2
|
Brachial circumference will be measured with a medical body tape measure and according to the ISAK recommendations. |
Year 2
|
|
Brachial circumference (cm).
Časové okno: Year 5
|
Brachial circumference will be measured with a medical body tape measure and according to the ISAK recommendations. |
Year 5
|
|
Calf circumference (cm).
Časové okno: Day 0
|
Calf circumference will be measured with a medical body tape measure and according to the ISAK recommendations |
Day 0
|
|
Calf circumference (cm).
Časové okno: Month 6
|
Calf circumference will be measured with a medical body tape measure and according to the ISAK recommendations |
Month 6
|
|
Calf circumference (cm).
Časové okno: Year 1
|
Calf circumference will be measured with a medical body tape measure and according to the ISAK recommendations |
Year 1
|
|
Calf circumference (cm).
Časové okno: Year 2
|
Calf circumference will be measured with a medical body tape measure and according to the ISAK recommendations |
Year 2
|
|
Calf circumference (cm).
Časové okno: Year 5
|
Calf circumference will be measured with a medical body tape measure and according to the ISAK recommendations |
Year 5
|
|
Body Mass Index (Kg/m²).
Časové okno: Day 0
|
BMI will be calculated (weight in kilograms divided by height in meters squared). |
Day 0
|
|
Body Mass Index (Kg/m²).
Časové okno: Month 6
|
BMI will be calculated (weight in kilograms divided by height in meters squared). |
Month 6
|
|
Body Mass Index (Kg/m²).
Časové okno: Year 1
|
BMI will be calculated (weight in kilograms divided by height in meters squared). |
Year 1
|
|
Body Mass Index (Kg/m²).
Časové okno: Year 2
|
BMI will be calculated (weight in kilograms divided by height in meters squared). |
Year 2
|
|
Body Mass Index (Kg/m²).
Časové okno: Year 5
|
BMI will be calculated (weight in kilograms divided by height in meters squared). |
Year 5
|
|
Body composition
Časové okno: Day 0
|
Body composition (muscle and fat) will be measured using he Bodystat® Impedance-meter. |
Day 0
|
|
Body composition
Časové okno: Month 6
|
Body composition (muscle and fat) will be measured using he Bodystat® Impedance-meter. |
Month 6
|
|
Body composition
Časové okno: Year 1
|
Body composition (muscle and fat) will be measured using he Bodystat® Impedance-meter. |
Year 1
|
|
Body composition
Časové okno: Year 2
|
Body composition (muscle and fat) will be measured using he Bodystat® Impedance-meter. |
Year 2
|
|
Body composition
Časové okno: Year 5
|
Body composition (muscle and fat) will be measured using he Bodystat® Impedance-meter. |
Year 5
|
|
T-score (DS).
Časové okno: DAy 0
|
- Description: T-score will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. |
DAy 0
|
|
T-score (DS).
Časové okno: Month 6
|
- Description: T-score will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. |
Month 6
|
|
T-score (DS).
Časové okno: Year 1
|
- Description: T-score will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. |
Year 1
|
|
T-score (DS).
Časové okno: Year 2
|
- Description: T-score will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. |
Year 2
|
|
T-score (DS).
Časové okno: Year 5
|
- Description: T-score will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. |
Year 5
|
|
Z-score (DS).
Časové okno: Day 0
|
Z-score will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer |
Day 0
|
|
Z-score (DS).
Časové okno: Month 6
|
Z-score will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer |
Month 6
|
|
Z-score (DS).
Časové okno: Year 1
|
Z-score will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer |
Year 1
|
|
Z-score (DS).
Časové okno: Year 2
|
Z-score will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer |
Year 2
|
|
Z-score (DS).
Časové okno: Year 5
|
Z-score will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer |
Year 5
|
|
Fat mass
Časové okno: Day 0
|
Fat mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. |
Day 0
|
|
Fat mass
Časové okno: Month 6
|
Fat mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. |
Month 6
|
|
Fat mass
Časové okno: Year 1
|
Fat mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. |
Year 1
|
|
Fat mass
Časové okno: Year 2
|
Fat mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. |
Year 2
|
|
Fat mass
Časové okno: Year 5
|
Fat mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. |
Year 5
|
|
Fat-free mass (%).
Časové okno: Day 0
|
: Fat free mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. |
Day 0
|
|
Fat-free mass (%).
Časové okno: Month 6
|
: Fat free mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. |
Month 6
|
|
Fat-free mass (%).
Časové okno: Year 1
|
: Fat free mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. |
Year 1
|
|
Fat-free mass (%).
Časové okno: Year 2
|
: Fat free mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. |
Year 2
|
|
Fat-free mass (%).
Časové okno: Year 5
|
: Fat free mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. |
Year 5
|
|
Fat mas index (Kg/m²).
Časové okno: Day 0
|
Fat mas index will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. |
Day 0
|
|
Fat mas index (Kg/m²).
Časové okno: Month 6
|
Fat mas index will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. |
Month 6
|
|
Fat mas index (Kg/m²).
Časové okno: Year 1
|
Fat mas index will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. |
Year 1
|
|
Fat mas index (Kg/m²).
Časové okno: Year 2
|
Fat mas index will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. |
Year 2
|
|
Fat mas index (Kg/m²).
Časové okno: Year 5
|
Fat mas index will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. |
Year 5
|
|
Ratio of android to gynoid fat mass.
Časové okno: Day 0
|
Ratio of android to gynoid fat mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer |
Day 0
|
|
Ratio of android to gynoid fat mass.
Časové okno: Month 6
|
Ratio of android to gynoid fat mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer |
Month 6
|
|
Ratio of android to gynoid fat mass.
Časové okno: Year 1
|
Ratio of android to gynoid fat mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer |
Year 1
|
|
Ratio of android to gynoid fat mass.
Časové okno: Year 2
|
Ratio of android to gynoid fat mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer |
Year 2
|
|
Ratio of android to gynoid fat mass.
Časové okno: Year 5
|
Ratio of android to gynoid fat mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer |
Year 5
|
|
Visceral adipose tissue (Kg).
Časové okno: Day 0
|
Visceral fat mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. |
Day 0
|
|
Visceral adipose tissue (Kg).
Časové okno: Month 6
|
Visceral fat mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. |
Month 6
|
|
Visceral adipose tissue (Kg).
Časové okno: Year 1
|
Visceral fat mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. |
Year 1
|
|
Visceral adipose tissue (Kg).
Časové okno: Year 2
|
Visceral fat mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. |
Year 2
|
|
Visceral adipose tissue (Kg).
Časové okno: Year 5
|
Visceral fat mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. |
Year 5
|
|
Fat-free mass index (kg/m²).
Časové okno: Day 0
|
: Fat-free mass index will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. |
Day 0
|
|
Fat-free mass index (kg/m²).
Časové okno: Month 6
|
: Fat-free mass index will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. |
Month 6
|
|
Fat-free mass index (kg/m²).
Časové okno: Year 1
|
: Fat-free mass index will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. |
Year 1
|
|
Fat-free mass index (kg/m²).
Časové okno: Year 2
|
: Fat-free mass index will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. |
Year 2
|
|
Fat-free mass index (kg/m²).
Časové okno: Year 5
|
: Fat-free mass index will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. |
Year 5
|
|
Appendicular fat-free mass index (Kg/m²).
Časové okno: Day 0
|
Appendicular fat-free mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. |
Day 0
|
|
Appendicular fat-free mass index (Kg/m²).
Časové okno: Month 6
|
Appendicular fat-free mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. |
Month 6
|
|
Appendicular fat-free mass index (Kg/m²).
Časové okno: Year 1
|
Appendicular fat-free mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. |
Year 1
|
|
Appendicular fat-free mass index (Kg/m²).
Časové okno: Year 2
|
Appendicular fat-free mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. |
Year 2
|
|
Appendicular fat-free mass index (Kg/m²).
Časové okno: Year 5
|
Appendicular fat-free mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. |
Year 5
|
|
Bone mass (Kg)
Časové okno: Day 0
|
- Description: Bone mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. |
Day 0
|
|
Bone mass (Kg)
Časové okno: Month 6
|
- Description: Bone mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. |
Month 6
|
|
Bone mass (Kg)
Časové okno: Year 1
|
- Description: Bone mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. |
Year 1
|
|
Bone mass (Kg)
Časové okno: Year 2
|
- Description: Bone mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. |
Year 2
|
|
Bone mass (Kg)
Časové okno: Year 5
|
- Description: Bone mass will be measured with the Hologic QDR 4500A dual-energy X-ray absorptiometer. |
Year 5
|
|
Daily caloric intake (Kcal/24h).
Časové okno: Day 0
|
Daily caloric intake will be estimated with a 24-hour (all foods and beverages consumed by the respondent in the past 24 hours). |
Day 0
|
|
Daily caloric intake (Kcal/24h).
Časové okno: Month 6
|
Daily caloric intake will be estimated with a 24-hour (all foods and beverages consumed by the respondent in the past 24 hours). |
Month 6
|
|
Daily caloric intake (Kcal/24h).
Časové okno: Year 1
|
Daily caloric intake will be estimated with a 24-hour (all foods and beverages consumed by the respondent in the past 24 hours). |
Year 1
|
|
Daily caloric intake (Kcal/24h).
Časové okno: Year 2
|
Daily caloric intake will be estimated with a 24-hour (all foods and beverages consumed by the respondent in the past 24 hours). |
Year 2
|
|
Daily caloric intake (Kcal/24h).
Časové okno: Year 5
|
Daily caloric intake will be estimated with a 24-hour (all foods and beverages consumed by the respondent in the past 24 hours). |
Year 5
|
|
Daily protein intake (in g and as a percentage of total caloric intake).
Časové okno: Day 0
|
Daily protein intake will be estimated with a 24-hour (all foods and beverages consumed by the respondent in the past 24 hours). |
Day 0
|
|
Daily protein intake (in g and as a percentage of total caloric intake).
Časové okno: Month 6
|
Daily protein intake (in g and as a percentage of total caloric intake). |
Month 6
|
|
Daily protein intake (in g and as a percentage of total caloric intake).
Časové okno: Year 1
|
Daily protein intake will be estimated with a 24-hour (all foods and beverages consumed by the respondent in the past 24 hours). |
Year 1
|
|
Daily protein intake (in g and as a percentage of total caloric intake).
Časové okno: Year 2
|
Daily protein intake will be estimated with a 24-hour (all foods and beverages consumed by the respondent in the past 24 hours). |
Year 2
|
|
Daily protein intake (in g and as a percentage of total caloric intake).
Časové okno: Year 5
|
Daily protein intake will be estimated with a 24-hour (all foods and beverages consumed by the respondent in the past 24 hours). |
Year 5
|
|
Daily carbohydrate intake (in g and as a percentage of total caloric intake).
Časové okno: Day 0
|
Daily carbohydrate intake will be estimated with a 24-hour (all foods and beverages consumed by the respondent in the past 24 hours). |
Day 0
|
|
Daily carbohydrate intake (in g and as a percentage of total caloric intake).
Časové okno: Month 6
|
Daily carbohydrate intake will be estimated with a 24-hour (all foods and beverages consumed by the respondent in the past 24 hours). |
Month 6
|
|
Daily carbohydrate intake (in g and as a percentage of total caloric intake).
Časové okno: Year 1
|
Daily carbohydrate intake will be estimated with a 24-hour (all foods and beverages consumed by the respondent in the past 24 hours). |
Year 1
|
|
Daily carbohydrate intake (in g and as a percentage of total caloric intake).
Časové okno: Year 2
|
Daily carbohydrate intake will be estimated with a 24-hour (all foods and beverages consumed by the respondent in the past 24 hours). |
Year 2
|
|
Daily carbohydrate intake (in g and as a percentage of total caloric intake).
Časové okno: Year 5
|
Daily carbohydrate intake will be estimated with a 24-hour (all foods and beverages consumed by the respondent in the past 24 hours). |
Year 5
|
|
Daily fat intake (in g and as a percentage of total caloric intake).
Časové okno: Day 0
|
Daily fat intake will be estimated with a 24-hour (all foods and beverages consumed by the respondent in the past 24 hours). |
Day 0
|
|
Daily fat intake (in g and as a percentage of total caloric intake).
Časové okno: Month 6
|
Daily fat intake will be estimated with a 24-hour (all foods and beverages consumed by the respondent in the past 24 hours). |
Month 6
|
|
Daily fat intake (in g and as a percentage of total caloric intake).
Časové okno: Year 1
|
Daily fat intake will be estimated with a 24-hour (all foods and beverages consumed by the respondent in the past 24 hours). |
Year 1
|
|
Daily fat intake (in g and as a percentage of total caloric intake).
Časové okno: Year 2
|
Daily fat intake will be estimated with a 24-hour (all foods and beverages consumed by the respondent in the past 24 hours). |
Year 2
|
|
Daily fat intake (in g and as a percentage of total caloric intake).
Časové okno: Year 5
|
Daily fat intake will be estimated with a 24-hour (all foods and beverages consumed by the respondent in the past 24 hours). |
Year 5
|
|
Nutritional status assessment
Časové okno: Day 0
|
Nutritional status assessment will be assessed with the Mini Nutritional Assessment Questionnaire. |
Day 0
|
|
Nutritional status assessment
Časové okno: Month 6
|
Nutritional status assessment will be assessed with the Mini Nutritional Assessment Questionnaire. |
Month 6
|
|
Nutritional status assessment
Časové okno: Year 1
|
Nutritional status assessment will be assessed with the Mini Nutritional Assessment Questionnaire. |
Year 1
|
|
Nutritional status assessment
Časové okno: Year 2
|
Nutritional status assessment will be assessed with the Mini Nutritional Assessment Questionnaire. |
Year 2
|
|
Nutritional status assessment
Časové okno: Year 5
|
Nutritional status assessment will be assessed with the Mini Nutritional Assessment Questionnaire. |
Year 5
|
|
Risk of undernutrition.
Časové okno: Day 0
|
Risk of undernutrition will be assessed with the Brocker Questionnaire |
Day 0
|
|
Risk of undernutrition.
Časové okno: Month 6
|
Risk of undernutrition will be assessed with the Brocker Questionnaire |
Month 6
|
|
Risk of undernutrition.
Časové okno: Year 1
|
Risk of undernutrition will be assessed with the Brocker Questionnaire |
Year 1
|
|
Risk of undernutrition.
Časové okno: Year 2
|
Risk of undernutrition will be assessed with the Brocker Questionnaire |
Year 2
|
|
Risk of undernutrition.
Časové okno: Year 5
|
Risk of undernutrition will be assessed with the Brocker Questionnaire |
Year 5
|
|
Basic biology.
Časové okno: Day 0
|
: Basic biology will be measured using endocrine assays (fasting blood glucose, HbA1c, HDL-c and LDL-c, TG, CPK) |
Day 0
|
|
Basic biology.
Časové okno: Month 6
|
: Basic biology will be measured using endocrine assays (fasting blood glucose, HbA1c, HDL-c and LDL-c, TG, CPK) |
Month 6
|
|
Basic biology.
Časové okno: Year 1
|
: Basic biology will be measured using endocrine assays (fasting blood glucose, HbA1c, HDL-c and LDL-c, TG, CPK) |
Year 1
|
|
Basic biology.
Časové okno: Year 2
|
: Basic biology will be measured using endocrine assays (fasting blood glucose, HbA1c, HDL-c and LDL-c, TG, CPK) |
Year 2
|
|
Basic biology.
Časové okno: Year 5
|
: Basic biology will be measured using endocrine assays (fasting blood glucose, HbA1c, HDL-c and LDL-c, TG, CPK) |
Year 5
|
|
Maximum voluntary isometric strength of the quadriceps muscles at 45° (Nm).
Časové okno: Day 0
|
: Maximum voluntary isometric strength of the quadriceps muscles will be measured with the HUMA® /NORM™ device. |
Day 0
|
|
Maximum voluntary isometric strength of the quadriceps muscles at 45° (Nm).
Časové okno: Month 6
|
: Maximum voluntary isometric strength of the quadriceps muscles will be measured with the HUMA® /NORM™ device. |
Month 6
|
|
Maximum voluntary isometric strength of the quadriceps muscles at 45° (Nm).
Časové okno: Year 1
|
: Maximum voluntary isometric strength of the quadriceps muscles will be measured with the HUMA® /NORM™ device. |
Year 1
|
|
Maximum voluntary isometric strength of the quadriceps muscles at 45° (Nm).
Časové okno: Year 2
|
: Maximum voluntary isometric strength of the quadriceps muscles will be measured with the HUMA® /NORM™ device. |
Year 2
|
|
Maximum voluntary isometric strength of the quadriceps muscles at 45° (Nm).
Časové okno: Year 5
|
: Maximum voluntary isometric strength of the quadriceps muscles will be measured with the HUMA® /NORM™ device. |
Year 5
|
|
Maximum voluntary isokinetic strength of the quadriceps muscles at 60°/s (Nm).
Časové okno: Day 0
|
- Description: Maximum voluntary isokinetic strength of the quadriceps muscles at 60°/s will be measured with the HUMA® /NORM™ device. |
Day 0
|
|
Maximum voluntary isokinetic strength of the quadriceps muscles at 60°/s (Nm).
Časové okno: Month 6
|
- Description: Maximum voluntary isokinetic strength of the quadriceps muscles at 60°/s will be measured with the HUMA® /NORM™ device. |
Month 6
|
|
Maximum voluntary isokinetic strength of the quadriceps muscles at 60°/s (Nm).
Časové okno: Year 1
|
- Description: Maximum voluntary isokinetic strength of the quadriceps muscles at 60°/s will be measured with the HUMA® /NORM™ device. |
Year 1
|
|
Maximum voluntary isokinetic strength of the quadriceps muscles at 60°/s (Nm).
Časové okno: Year 2
|
- Description: Maximum voluntary isokinetic strength of the quadriceps muscles at 60°/s will be measured with the HUMA® /NORM™ device. |
Year 2
|
|
Maximum voluntary isokinetic strength of the quadriceps muscles at 60°/s (Nm).
Časové okno: Year 5
|
- Description: Maximum voluntary isokinetic strength of the quadriceps muscles at 60°/s will be measured with the HUMA® /NORM™ device. |
Year 5
|
|
Maximum voluntary isokinetic strength of the quadriceps muscles at 240°/s (Nm).
Časové okno: Day 0
|
Maximum voluntary isokinetic strength of the quadriceps muscles at 240°/s will be measured with the HUMA® /NORM™ device. |
Day 0
|
|
Maximum voluntary isokinetic strength of the quadriceps muscles at 240°/s (Nm).
Časové okno: Month 6
|
Maximum voluntary isokinetic strength of the quadriceps muscles at 240°/s will be measured with the HUMA® /NORM™ device. |
Month 6
|
|
Maximum voluntary isokinetic strength of the quadriceps muscles at 240°/s (Nm).
Časové okno: Year 1
|
Maximum voluntary isokinetic strength of the quadriceps muscles at 240°/s will be measured with the HUMA® /NORM™ device. |
Year 1
|
|
Maximum voluntary isokinetic strength of the quadriceps muscles at 240°/s (Nm).
Časové okno: Year 2
|
Maximum voluntary isokinetic strength of the quadriceps muscles at 240°/s will be measured with the HUMA® /NORM™ device. |
Year 2
|
|
Maximum voluntary isokinetic strength of the quadriceps muscles at 240°/s (Nm).
Časové okno: Year 5
|
Maximum voluntary isokinetic strength of the quadriceps muscles at 240°/s will be measured with the HUMA® /NORM™ device. |
Year 5
|
|
Maximum voluntary isokinetic strength of the quadriceps muscles at 30°/s (eccentric contraction) (Nm).
Časové okno: Day 0
|
Maximum voluntary isokinetic strength of the quadriceps muscles at 30°/s will be measured with the HUMA® /NORM™ device. |
Day 0
|
|
Maximum voluntary isokinetic strength of the quadriceps muscles at 30°/s (eccentric contraction) (Nm).
Časové okno: Month 6
|
Maximum voluntary isokinetic strength of the quadriceps muscles at 30°/s will be measured with the HUMA® /NORM™ device. |
Month 6
|
|
Maximum voluntary isokinetic strength of the quadriceps muscles at 30°/s (eccentric contraction) (Nm).
Časové okno: Year 1
|
Maximum voluntary isokinetic strength of the quadriceps muscles at 30°/s will be measured with the HUMA® /NORM™ device. |
Year 1
|
|
Maximum voluntary isokinetic strength of the quadriceps muscles at 30°/s (eccentric contraction) (Nm).
Časové okno: Year 2
|
Maximum voluntary isokinetic strength of the quadriceps muscles at 30°/s will be measured with the HUMA® /NORM™ device. |
Year 2
|
|
Maximum voluntary isokinetic strength of the quadriceps muscles at 30°/s (eccentric contraction) (Nm).
Časové okno: Year 5
|
Maximum voluntary isokinetic strength of the quadriceps muscles at 30°/s will be measured with the HUMA® /NORM™ device. |
Year 5
|
|
Maximum voluntary isokinetic strength of the hamstring muscles at 60°/s (Nm).
Časové okno: Day 0
|
Maximum voluntary isokinetic strength of the hamstring muscles at 60°/s will be measured with the HUMA® /NORM™ device. |
Day 0
|
|
Maximum voluntary isokinetic strength of the hamstring muscles at 60°/s (Nm).
Časové okno: Month 6
|
Maximum voluntary isokinetic strength of the hamstring muscles at 60°/s will be measured with the HUMA® /NORM™ device. |
Month 6
|
|
Maximum voluntary isokinetic strength of the hamstring muscles at 60°/s (Nm).
Časové okno: Year 1
|
Maximum voluntary isokinetic strength of the hamstring muscles at 60°/s will be measured with the HUMA® /NORM™ device. |
Year 1
|
|
Maximum voluntary isokinetic strength of the hamstring muscles at 60°/s (Nm).
Časové okno: Year 2
|
Maximum voluntary isokinetic strength of the hamstring muscles at 60°/s will be measured with the HUMA® /NORM™ device. |
Year 2
|
|
Maximum voluntary isokinetic strength of the hamstring muscles at 60°/s (Nm).
Časové okno: Year 5
|
Maximum voluntary isokinetic strength of the hamstring muscles at 60°/s will be measured with the HUMA® /NORM™ device. |
Year 5
|
|
Maximum voluntary isokinetic strength of the hamstring muscles at 240°/s (Nm).
Časové okno: Day 0
|
- Description: Maximum voluntary isokinetic strength of the hamstring muscles at 240°/s will be measured with the HUMA® /NORM™ device. |
Day 0
|
|
Maximum voluntary isokinetic strength of the hamstring muscles at 240°/s (Nm).
Časové okno: Month 6
|
- Description: Maximum voluntary isokinetic strength of the hamstring muscles at 240°/s will be measured with the HUMA® /NORM™ device. |
Month 6
|
|
Maximum voluntary isokinetic strength of the hamstring muscles at 240°/s (Nm).
Časové okno: Year 1
|
- Description: Maximum voluntary isokinetic strength of the hamstring muscles at 240°/s will be measured with the HUMA® /NORM™ device. |
Year 1
|
|
Maximum voluntary isokinetic strength of the hamstring muscles at 240°/s (Nm).
Časové okno: Year 2
|
- Description: Maximum voluntary isokinetic strength of the hamstring muscles at 240°/s will be measured with the HUMA® /NORM™ device. |
Year 2
|
|
Maximum voluntary isokinetic strength of the hamstring muscles at 240°/s (Nm).
Časové okno: Year 5
|
- Description: Maximum voluntary isokinetic strength of the hamstring muscles at 240°/s will be measured with the HUMA® /NORM™ device. |
Year 5
|
|
Maximum voluntary isokinetic strength of the hamstring muscles at 30°/s (eccentric contraction) (Nm).
Časové okno: Day 0
|
Maximum voluntary isokinetic strength of the hamstring muscles at 30°/s will be measured with the HUMA® /NORM™ device. |
Day 0
|
|
Maximum voluntary isokinetic strength of the hamstring muscles at 30°/s (eccentric contraction) (Nm).
Časové okno: Month 6
|
Maximum voluntary isokinetic strength of the hamstring muscles at 30°/s will be measured with the HUMA® /NORM™ device. |
Month 6
|
|
Maximum voluntary isokinetic strength of the hamstring muscles at 30°/s (eccentric contraction) (Nm).
Časové okno: Year 1
|
Maximum voluntary isokinetic strength of the hamstring muscles at 30°/s will be measured with the HUMA® /NORM™ device. |
Year 1
|
|
Maximum voluntary isokinetic strength of the hamstring muscles at 30°/s (eccentric contraction) (Nm).
Časové okno: Year 2
|
Maximum voluntary isokinetic strength of the hamstring muscles at 30°/s will be measured with the HUMA® /NORM™ device. |
Year 2
|
|
Maximum voluntary isokinetic strength of the hamstring muscles at 30°/s (eccentric contraction) (Nm).
Časové okno: Year 5
|
Maximum voluntary isokinetic strength of the hamstring muscles at 30°/s will be measured with the HUMA® /NORM™ device. |
Year 5
|
|
Endurance coefficient of the quadriceps muscles at 180°/s.
Časové okno: Day 0
|
Endurance coefficient will be estimated as a Σ Peak torque ratio of the last 3 contractions on the first 3 at 180°/s with the HUMA® /NORM™ device. |
Day 0
|
|
Endurance coefficient of the quadriceps muscles at 180°/s.
Časové okno: Month 6
|
Endurance coefficient will be estimated as a Σ Peak torque ratio of the last 3 contractions on the first 3 at 180°/s with the HUMA® /NORM™ device. |
Month 6
|
|
Endurance coefficient of the quadriceps muscles at 180°/s.
Časové okno: Year 1
|
Endurance coefficient will be estimated as a Σ Peak torque ratio of the last 3 contractions on the first 3 at 180°/s with the HUMA® /NORM™ device. |
Year 1
|
|
Endurance coefficient of the quadriceps muscles at 180°/s.
Časové okno: Year 2
|
Endurance coefficient will be estimated as a Σ Peak torque ratio of the last 3 contractions on the first 3 at 180°/s with the HUMA® /NORM™ device. |
Year 2
|
|
Endurance coefficient of the quadriceps muscles at 180°/s.
Časové okno: Year 5
|
Endurance coefficient will be estimated as a Σ Peak torque ratio of the last 3 contractions on the first 3 at 180°/s with the HUMA® /NORM™ device. |
Year 5
|
|
Endurance coefficient of the hamstring muscles at 180°/s.
Časové okno: Day 0
|
Endurance coefficient will be estimated as a Σ Peak torque ratio of the last 3 contractions on the first 3 at 180°/s with the HUMA® /NORM™ device.. |
Day 0
|
|
Endurance coefficient of the hamstring muscles at 180°/s.
Časové okno: Month 6
|
Endurance coefficient will be estimated as a Σ Peak torque ratio of the last 3 contractions on the first 3 at 180°/s with the HUMA® /NORM™ device.. |
Month 6
|
|
Endurance coefficient of the hamstring muscles at 180°/s.
Časové okno: Year 1
|
Endurance coefficient will be estimated as a Σ Peak torque ratio of the last 3 contractions on the first 3 at 180°/s with the HUMA® /NORM™ device.. |
Year 1
|
|
Endurance coefficient of the hamstring muscles at 180°/s.
Časové okno: Year 2
|
Endurance coefficient will be estimated as a Σ Peak torque ratio of the last 3 contractions on the first 3 at 180°/s with the HUMA® /NORM™ device.. |
Year 2
|
|
Endurance coefficient of the hamstring muscles at 180°/s.
Časové okno: Year 5
|
Endurance coefficient will be estimated as a Σ Peak torque ratio of the last 3 contractions on the first 3 at 180°/s with the HUMA® /NORM™ device.. |
Year 5
|
|
Functional ratio
Časové okno: Day 0
|
Functional ratio will be estimated by dividing the maximum voluntary isokinetic strength of the hamstring muscles at 60°/s with the maximum voluntary isokinetic strength of the quadriceps muscles at 60°/s. |
Day 0
|
|
Functional ratio
Časové okno: Month 6
|
Functional ratio will be estimated by dividing the maximum voluntary isokinetic strength of the hamstring muscles at 60°/s with the maximum voluntary isokinetic strength of the quadriceps muscles at 60°/s. |
Month 6
|
|
Functional ratio
Časové okno: Year 1
|
Functional ratio will be estimated by dividing the maximum voluntary isokinetic strength of the hamstring muscles at 60°/s with the maximum voluntary isokinetic strength of the quadriceps muscles at 60°/s. |
Year 1
|
|
Functional ratio
Časové okno: Year 2
|
Functional ratio will be estimated by dividing the maximum voluntary isokinetic strength of the hamstring muscles at 60°/s with the maximum voluntary isokinetic strength of the quadriceps muscles at 60°/s. |
Year 2
|
|
Functional ratio
Časové okno: Year 5
|
Functional ratio will be estimated by dividing the maximum voluntary isokinetic strength of the hamstring muscles at 60°/s with the maximum voluntary isokinetic strength of the quadriceps muscles at 60°/s. |
Year 5
|
|
Mixed ratio
Časové okno: Day 0
|
- Mixed ratio will be estimated by dividing the maximum voluntary isokinetic strength of the hamstring muscles at 30°/s (eccentric contraction) with the maximum voluntary isokinetic strength of the quadriceps muscles at 240°/s Title: Maximum voluntary strength of the quadriceps muscles at 60°/s. |
Day 0
|
|
Mixed ratio
Časové okno: Month 6
|
- Mixed ratio will be estimated by dividing the maximum voluntary isokinetic strength of the hamstring muscles at 30°/s (eccentric contraction) with the maximum voluntary isokinetic strength of the quadriceps muscles at 240°/s Title: Maximum voluntary strength of the quadriceps muscles at 60°/s. |
Month 6
|
|
Mixed ratio
Časové okno: Year 1
|
- Mixed ratio will be estimated by dividing the maximum voluntary isokinetic strength of the hamstring muscles at 30°/s (eccentric contraction) with the maximum voluntary isokinetic strength of the quadriceps muscles at 240°/s Title: Maximum voluntary strength of the quadriceps muscles at 60°/s. |
Year 1
|
|
Mixed ratio
Časové okno: Year 2
|
- Mixed ratio will be estimated by dividing the maximum voluntary isokinetic strength of the hamstring muscles at 30°/s (eccentric contraction) with the maximum voluntary isokinetic strength of the quadriceps muscles at 240°/s Title: Maximum voluntary strength of the quadriceps muscles at 60°/s. |
Year 2
|
|
Mixed ratio
Časové okno: Year 5
|
- Mixed ratio will be estimated by dividing the maximum voluntary isokinetic strength of the hamstring muscles at 30°/s (eccentric contraction) with the maximum voluntary isokinetic strength of the quadriceps muscles at 240°/s Title: Maximum voluntary strength of the quadriceps muscles at 60°/s. |
Year 5
|
|
Maximum voluntary hand grip strength (Kg).
Časové okno: Day 0
|
Maximum voluntary hand grip strength will be measured with the Jamar® hydraulic dynamometer and with the Baseline® pneumatic dynamometer. |
Day 0
|
|
Maximum voluntary hand grip strength (Kg).
Časové okno: Month 6
|
Maximum voluntary hand grip strength will be measured with the Jamar® hydraulic dynamometer and with the Baseline® pneumatic dynamometer. |
Month 6
|
|
Maximum voluntary hand grip strength (Kg).
Časové okno: Year 1
|
Maximum voluntary hand grip strength will be measured with the Jamar® hydraulic dynamometer and with the Baseline® pneumatic dynamometer. |
Year 1
|
|
Maximum voluntary hand grip strength (Kg).
Časové okno: Year 2
|
Maximum voluntary hand grip strength will be measured with the Jamar® hydraulic dynamometer and with the Baseline® pneumatic dynamometer. |
Year 2
|
|
Maximum voluntary hand grip strength (Kg).
Časové okno: Year 5
|
Maximum voluntary hand grip strength will be measured with the Jamar® hydraulic dynamometer and with the Baseline® pneumatic dynamometer. |
Year 5
|
|
Maximum voluntary pinch strength (Kg).
Časové okno: Day 0
|
Maximum voluntary pinch strength will be measured with the Baseline® pinch gauche test mechanical dynamometer. |
Day 0
|
|
Maximum voluntary pinch strength (Kg).
Časové okno: Month 6
|
Maximum voluntary pinch strength will be measured with the Baseline® pinch gauche test mechanical dynamometer. |
Month 6
|
|
Maximum voluntary pinch strength (Kg).
Časové okno: Year 1
|
Maximum voluntary pinch strength will be measured with the Baseline® pinch gauche test mechanical dynamometer. |
Year 1
|
|
Maximum voluntary pinch strength (Kg).
Časové okno: Year 2
|
Maximum voluntary pinch strength will be measured with the Baseline® pinch gauche test mechanical dynamometer. |
Year 2
|
|
Maximum voluntary pinch strength (Kg).
Časové okno: Year 5
|
Maximum voluntary pinch strength will be measured with the Baseline® pinch gauche test mechanical dynamometer. |
Year 5
|
|
Hip passive joint range
Časové okno: Day 0
|
Hip joint range will be measured with a medical goniometer. |
Day 0
|
|
Hip passive joint range
Časové okno: Month 6
|
Hip joint range will be measured with a medical goniometer. |
Month 6
|
|
Hip passive joint range
Časové okno: Year 1
|
Hip joint range will be measured with a medical goniometer. |
Year 1
|
|
Hip passive joint range
Časové okno: Year 2
|
Hip joint range will be measured with a medical goniometer. |
Year 2
|
|
Hip passive joint range
Časové okno: Year 5
|
Hip joint range will be measured with a medical goniometer. |
Year 5
|
|
Knee passive joint range.
Časové okno: Day 0
|
Knee joint range will be measured with a medical goniometer. |
Day 0
|
|
Knee passive joint range.
Časové okno: Month 6
|
Knee joint range will be measured with a medical goniometer. |
Month 6
|
|
Knee passive joint range.
Časové okno: Year 1
|
Knee joint range will be measured with a medical goniometer. |
Year 1
|
|
Knee passive joint range.
Časové okno: Year 2
|
Knee joint range will be measured with a medical goniometer. |
Year 2
|
|
Knee passive joint range.
Časové okno: Year 5
|
Knee joint range will be measured with a medical goniometer. |
Year 5
|
|
Ankle passive joint range
Časové okno: Day 0
|
Ankle joint range will be measured with a medical goniometer. |
Day 0
|
|
Ankle passive joint range
Časové okno: Month 6
|
Ankle joint range will be measured with a medical goniometer. |
Month 6
|
|
Ankle passive joint range
Časové okno: Year 1
|
Ankle joint range will be measured with a medical goniometer. |
Year 1
|
|
Ankle passive joint range
Časové okno: Year 2
|
Ankle joint range will be measured with a medical goniometer. |
Year 2
|
|
Ankle passive joint range
Časové okno: Year 5
|
Ankle joint range will be measured with a medical goniometer. |
Year 5
|
|
Lower and upper limb muscle power assessment (MRC)
Časové okno: Day 0
|
Lower and upper limb muscle power assessment will be performed by an experienced physician. |
Day 0
|
|
Lower and upper limb muscle power assessment (MRC)
Časové okno: Month 6
|
Lower and upper limb muscle power assessment will be performed by an experienced physician. |
Month 6
|
|
Lower and upper limb muscle power assessment (MRC)
Časové okno: Year 1
|
Lower and upper limb muscle power assessment will be performed by an experienced physician. |
Year 1
|
|
Lower and upper limb muscle power assessment (MRC)
Časové okno: Year 2
|
Lower and upper limb muscle power assessment will be performed by an experienced physician. |
Year 2
|
|
Lower and upper limb muscle power assessment (MRC)
Časové okno: Year 5
|
Lower and upper limb muscle power assessment will be performed by an experienced physician. |
Year 5
|
|
Statokinesigram surface area (mm²)
Časové okno: Day 0
|
Statokinesigram surface area will be measured with the STATIPRO® static posturography platform. |
Day 0
|
|
Statokinesigram surface area (mm²)
Časové okno: Month 6
|
Statokinesigram surface area will be measured with the STATIPRO® static posturography platform. |
Month 6
|
|
Statokinesigram surface area (mm²)
Časové okno: Year 1
|
Statokinesigram surface area will be measured with the STATIPRO® static posturography platform. |
Year 1
|
|
Statokinesigram surface area (mm²)
Časové okno: Year 2
|
Statokinesigram surface area will be measured with the STATIPRO® static posturography platform. |
Year 2
|
|
Statokinesigram surface area (mm²)
Časové okno: Year 5
|
Statokinesigram surface area will be measured with the STATIPRO® static posturography platform. |
Year 5
|
|
Stabilogram length (mm).
Časové okno: Day 0
|
Stabilogram length will be measured with the STATIPRO® static posturography platform |
Day 0
|
|
Stabilogram length (mm).
Časové okno: Month 6
|
Stabilogram length will be measured with the STATIPRO® static posturography platform |
Month 6
|
|
Stabilogram length (mm).
Časové okno: Year 1
|
Stabilogram length will be measured with the STATIPRO® static posturography platform |
Year 1
|
|
Stabilogram length (mm).
Časové okno: Year 2
|
Stabilogram length will be measured with the STATIPRO® static posturography platform |
Year 2
|
|
Stabilogram length (mm).
Časové okno: Year 5
|
Stabilogram length will be measured with the STATIPRO® static posturography platform |
Year 5
|
|
Maximal deflection (forward, backward left and right).
Časové okno: Day 0
|
Maximal deflection will be measured with the STATIPRO® static posturography platform. |
Day 0
|
|
Maximal deflection (forward, backward left and right).
Časové okno: Month 6
|
Maximal deflection will be measured with the STATIPRO® static posturography platform. |
Month 6
|
|
Maximal deflection (forward, backward left and right).
Časové okno: Year 1
|
Maximal deflection will be measured with the STATIPRO® static posturography platform. |
Year 1
|
|
Maximal deflection (forward, backward left and right).
Časové okno: Year 2
|
Maximal deflection will be measured with the STATIPRO® static posturography platform. |
Year 2
|
|
Maximal deflection (forward, backward left and right).
Časové okno: Year 5
|
Maximal deflection will be measured with the STATIPRO® static posturography platform. |
Year 5
|
|
Velocity variations (mm/s).
Časové okno: Day 0
|
: Velocity variations will be measured with the STATIPRO® static posturography platform. |
Day 0
|
|
Velocity variations (mm/s).
Časové okno: Month 6
|
: Velocity variations will be measured with the STATIPRO® static posturography platform. |
Month 6
|
|
Velocity variations (mm/s).
Časové okno: Year 1
|
: Velocity variations will be measured with the STATIPRO® static posturography platform. |
Year 1
|
|
Velocity variations (mm/s).
Časové okno: Year 2
|
: Velocity variations will be measured with the STATIPRO® static posturography platform. |
Year 2
|
|
Velocity variations (mm/s).
Časové okno: Year 5
|
: Velocity variations will be measured with the STATIPRO® static posturography platform. |
Year 5
|
|
: Romberg ratio according to sway area
Časové okno: Day 0
|
Romberg ratio will be measured with the STATIPRO® static posturography platform. |
Day 0
|
|
: Romberg ratio according to sway area
Časové okno: Month 6
|
Romberg ratio will be measured with the STATIPRO® static posturography platform. |
Month 6
|
|
: Romberg ratio according to sway area
Časové okno: Year 1
|
Romberg ratio will be measured with the STATIPRO® static posturography platform. |
Year 1
|
|
: Romberg ratio according to sway area
Časové okno: Year 2
|
Romberg ratio will be measured with the STATIPRO® static posturography platform. |
Year 2
|
|
: Romberg ratio according to sway area
Časové okno: Year 5
|
Romberg ratio will be measured with the STATIPRO® static posturography platform. |
Year 5
|
|
Romberg ratio according to center of pressure path length
Časové okno: Day 0
|
Romberg ratio will be measured with the STATIPRO® static posturography platform. |
Day 0
|
|
Romberg ratio according to center of pressure path length
Časové okno: Month 6
|
Romberg ratio will be measured with the STATIPRO® static posturography platform. |
Month 6
|
|
Romberg ratio according to center of pressure path length
Časové okno: Year 1
|
Romberg ratio will be measured with the STATIPRO® static posturography platform. |
Year 1
|
|
Romberg ratio according to center of pressure path length
Časové okno: Year 2
|
Romberg ratio will be measured with the STATIPRO® static posturography platform. |
Year 2
|
|
Romberg ratio according to center of pressure path length
Časové okno: Year 5
|
Romberg ratio will be measured with the STATIPRO® static posturography platform. |
Year 5
|
|
: Plantar pressure ratio sway area.
Časové okno: Day 0
|
Plantar pressure ratio sway area will be measured with the STATIPRO® static posturography platform. |
Day 0
|
|
: Plantar pressure ratio sway area.
Časové okno: Month 6
|
Plantar pressure ratio sway area will be measured with the STATIPRO® static posturography platform. |
Month 6
|
|
: Plantar pressure ratio sway area.
Časové okno: Year 1
|
Plantar pressure ratio sway area will be measured with the STATIPRO® static posturography platform. |
Year 1
|
|
: Plantar pressure ratio sway area.
Časové okno: Year 2
|
Plantar pressure ratio sway area will be measured with the STATIPRO® static posturography platform. |
Year 2
|
|
: Plantar pressure ratio sway area.
Časové okno: Year 5
|
Plantar pressure ratio sway area will be measured with the STATIPRO® static posturography platform. |
Year 5
|
|
Plantar pressure ratio length.
Časové okno: Day 0
|
Plantar pressure ratio length will be measured with the STATIPRO® static posturography platform. |
Day 0
|
|
Plantar pressure ratio length.
Časové okno: Month 6
|
Plantar pressure ratio length will be measured with the STATIPRO® static posturography platform. |
Month 6
|
|
Plantar pressure ratio length.
Časové okno: Year 1
|
Plantar pressure ratio length will be measured with the STATIPRO® static posturography platform. |
Year 1
|
|
Plantar pressure ratio length.
Časové okno: Year 2
|
Plantar pressure ratio length will be measured with the STATIPRO® static posturography platform. |
Year 2
|
|
Plantar pressure ratio length.
Časové okno: Year 5
|
Plantar pressure ratio length will be measured with the STATIPRO® static posturography platform. |
Year 5
|
|
Walking velocity (cm/s).
Časové okno: Day 0
|
Walking velocity will be measured with the GAITRite® Electronic Walkway. |
Day 0
|
|
Walking velocity (cm/s).
Časové okno: Month 6
|
Walking velocity will be measured with the GAITRite® Electronic Walkway. |
Month 6
|
|
Walking velocity (cm/s).
Časové okno: Year 1
|
Walking velocity will be measured with the GAITRite® Electronic Walkway. |
Year 1
|
|
Walking velocity (cm/s).
Časové okno: Year 2
|
Walking velocity will be measured with the GAITRite® Electronic Walkway. |
Year 2
|
|
Walking velocity (cm/s).
Časové okno: Year 5
|
Walking velocity will be measured with the GAITRite® Electronic Walkway. |
Year 5
|
|
Cadence (steps/min).
Časové okno: Day 0
|
: Cadence will be measured with the GAITRite® Electronic Walkway. |
Day 0
|
|
Cadence (steps/min).
Časové okno: Month 6
|
: Cadence will be measured with the GAITRite® Electronic Walkway. |
Month 6
|
|
Cadence (steps/min).
Časové okno: Year 1
|
: Cadence will be measured with the GAITRite® Electronic Walkway. |
Year 1
|
|
Cadence (steps/min).
Časové okno: Year 2
|
: Cadence will be measured with the GAITRite® Electronic Walkway. |
Year 2
|
|
Cadence (steps/min).
Časové okno: Year 5
|
: Cadence will be measured with the GAITRite® Electronic Walkway. |
Year 5
|
|
Step length (left and right foot) (cm)
Časové okno: DAy 0
|
Step length will be measured with the GAITRite® Electronic Walkway. |
DAy 0
|
|
Step length (left and right foot) (cm)
Časové okno: Month 6
|
Step length will be measured with the GAITRite® Electronic Walkway. |
Month 6
|
|
Step length (left and right foot) (cm)
Časové okno: Year 1
|
Step length will be measured with the GAITRite® Electronic Walkway. |
Year 1
|
|
Step length (left and right foot) (cm)
Časové okno: Year 2
|
Step length will be measured with the GAITRite® Electronic Walkway. |
Year 2
|
|
Step length (left and right foot) (cm)
Časové okno: Year 5
|
Step length will be measured with the GAITRite® Electronic Walkway. |
Year 5
|
|
Stride length (cm).
Časové okno: Day 0
|
Stride length will be measured with the GAITRite® Electronic Walkway. |
Day 0
|
|
Stride length (cm).
Časové okno: month 6
|
Stride length will be measured with the GAITRite® Electronic Walkway. |
month 6
|
|
Stride length (cm).
Časové okno: year 1
|
Stride length will be measured with the GAITRite® Electronic Walkway. |
year 1
|
|
Stride length (cm).
Časové okno: year 2
|
Stride length will be measured with the GAITRite® Electronic Walkway. |
year 2
|
|
Stride length (cm).
Časové okno: year 5
|
Stride length will be measured with the GAITRite® Electronic Walkway. |
year 5
|
|
Single support time left and right foot (s).
Časové okno: Day 0
|
Single support time will be measured with the GAITRite® Electronic Walkway. |
Day 0
|
|
Single support time left and right foot (s).
Časové okno: Month 6
|
Single support time will be measured with the GAITRite® Electronic Walkway. |
Month 6
|
|
Single support time left and right foot (s).
Časové okno: Year 1
|
Single support time will be measured with the GAITRite® Electronic Walkway. |
Year 1
|
|
Single support time left and right foot (s).
Časové okno: Year 2
|
Single support time will be measured with the GAITRite® Electronic Walkway. |
Year 2
|
|
Single support time left and right foot (s).
Časové okno: Year 5
|
Single support time will be measured with the GAITRite® Electronic Walkway. |
Year 5
|
|
Double support time (s).
Časové okno: Day 0
|
: Double support time will be measured with the GAITRite® Electronic Walkway. |
Day 0
|
|
Double support time (s).
Časové okno: Month 6
|
: Double support time will be measured with the GAITRite® Electronic Walkway. |
Month 6
|
|
Double support time (s).
Časové okno: YEar 1
|
: Double support time will be measured with the GAITRite® Electronic Walkway. |
YEar 1
|
|
Double support time (s).
Časové okno: Year 2
|
: Double support time will be measured with the GAITRite® Electronic Walkway. |
Year 2
|
|
Double support time (s).
Časové okno: Year 5
|
: Double support time will be measured with the GAITRite® Electronic Walkway. |
Year 5
|
|
Swing time (s).
Časové okno: Day 0
|
: Swing time will be measured with the GAITRite® Electronic Walkway. |
Day 0
|
|
Swing time (s).
Časové okno: Month 6
|
: Swing time will be measured with the GAITRite® Electronic Walkway. |
Month 6
|
|
Swing time (s).
Časové okno: Year 1
|
: Swing time will be measured with the GAITRite® Electronic Walkway. |
Year 1
|
|
Swing time (s).
Časové okno: Year 2
|
: Swing time will be measured with the GAITRite® Electronic Walkway. |
Year 2
|
|
Swing time (s).
Časové okno: Year 5
|
: Swing time will be measured with the GAITRite® Electronic Walkway. |
Year 5
|
|
Swing phase (as a % of walking cycle).
Časové okno: DAy 0
|
: Swing phase will be measured with the GAITRite® Electronic Walkway. |
DAy 0
|
|
Swing phase (as a % of walking cycle).
Časové okno: Month 6
|
: Swing phase will be measured with the GAITRite® Electronic Walkway. |
Month 6
|
|
Swing phase (as a % of walking cycle).
Časové okno: Year 1
|
: Swing phase will be measured with the GAITRite® Electronic Walkway. |
Year 1
|
|
Swing phase (as a % of walking cycle).
Časové okno: Year 2
|
: Swing phase will be measured with the GAITRite® Electronic Walkway. |
Year 2
|
|
Swing phase (as a % of walking cycle).
Časové okno: Year 5
|
: Swing phase will be measured with the GAITRite® Electronic Walkway. |
Year 5
|
|
Stance phase (as a % of walking cycle).
Časové okno: Day 0
|
Stance phase will be measured with the GAITRite® Electronic Walkway. |
Day 0
|
|
Stance phase (as a % of walking cycle).
Časové okno: Month 6
|
Stance phase will be measured with the GAITRite® Electronic Walkway. |
Month 6
|
|
Stance phase (as a % of walking cycle).
Časové okno: Year 1
|
Stance phase will be measured with the GAITRite® Electronic Walkway. |
Year 1
|
|
Stance phase (as a % of walking cycle).
Časové okno: Year 2
|
Stance phase will be measured with the GAITRite® Electronic Walkway. |
Year 2
|
|
Stance phase (as a % of walking cycle).
Časové okno: Year 5
|
Stance phase will be measured with the GAITRite® Electronic Walkway. |
Year 5
|
|
Vo2max (maximal oxygen consumption) (mL/Kg/min).
Časové okno: Day 0
|
: Vo2max will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer. |
Day 0
|
|
Vo2max (maximal oxygen consumption) (mL/Kg/min).
Časové okno: Month 6
|
: Vo2max will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer. |
Month 6
|
|
Vo2max (maximal oxygen consumption) (mL/Kg/min).
Časové okno: Year 1
|
: Vo2max will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer. |
Year 1
|
|
Vo2max (maximal oxygen consumption) (mL/Kg/min).
Časové okno: Year 2
|
: Vo2max will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer. |
Year 2
|
|
Vo2max (maximal oxygen consumption) (mL/Kg/min).
Časové okno: Year 5
|
: Vo2max will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer. |
Year 5
|
|
Maximum heart rate (bpm).
Časové okno: Day 0
|
Maximum heart rate will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer. |
Day 0
|
|
Maximum heart rate (bpm).
Časové okno: Month 6
|
Maximum heart rate will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer. |
Month 6
|
|
Maximum heart rate (bpm).
Časové okno: Year 1
|
Maximum heart rate will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer. |
Year 1
|
|
Maximum heart rate (bpm).
Časové okno: Year 2
|
Maximum heart rate will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer. |
Year 2
|
|
Maximum heart rate (bpm).
Časové okno: Year 5
|
Maximum heart rate will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer. |
Year 5
|
|
Maximum power (Watts).
Časové okno: Day 0
|
Maximum power will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer. |
Day 0
|
|
Maximum power (Watts).
Časové okno: Month 6
|
Maximum power will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer. |
Month 6
|
|
Maximum power (Watts).
Časové okno: Year 1
|
Maximum power will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer. |
Year 1
|
|
Maximum power (Watts).
Časové okno: Year 2
|
Maximum power will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer. |
Year 2
|
|
Maximum power (Watts).
Časové okno: Year 5
|
Maximum power will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer. |
Year 5
|
|
Threshold power (Watts).
Časové okno: Day 0
|
Threshold power will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer. |
Day 0
|
|
Threshold power (Watts).
Časové okno: Month 6
|
Threshold power will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer. |
Month 6
|
|
Threshold power (Watts).
Časové okno: Year 1
|
Threshold power will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer. |
Year 1
|
|
Threshold power (Watts).
Časové okno: Year 2
|
Threshold power will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer. |
Year 2
|
|
Threshold power (Watts).
Časové okno: Year 5
|
Threshold power will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer. |
Year 5
|
|
Threshold heart rate (bpm).
Časové okno: DAy 0
|
Threshold heart will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer. |
DAy 0
|
|
Threshold heart rate (bpm).
Časové okno: Month 6
|
Threshold heart will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer. |
Month 6
|
|
Threshold heart rate (bpm).
Časové okno: Year 1
|
Threshold heart will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer. |
Year 1
|
|
Threshold heart rate (bpm).
Časové okno: Year 2
|
Threshold heart will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer. |
Year 2
|
|
Threshold heart rate (bpm).
Časové okno: Year 5
|
Threshold heart will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer. |
Year 5
|
|
Forced vital Capacity (L).
Časové okno: Day 0
|
: Forced vital Capacity will be measured with a spirometry test. |
Day 0
|
|
Forced vital Capacity (L).
Časové okno: Month 6
|
: Forced vital Capacity will be measured with a spirometry test. |
Month 6
|
|
Forced vital Capacity (L).
Časové okno: Year 1
|
: Forced vital Capacity will be measured with a spirometry test. |
Year 1
|
|
Forced vital Capacity (L).
Časové okno: Year 2
|
: Forced vital Capacity will be measured with a spirometry test. |
Year 2
|
|
Forced vital Capacity (L).
Časové okno: Year 5
|
: Forced vital Capacity will be measured with a spirometry test. |
Year 5
|
|
Forced Expiratory volume (L)
Časové okno: Day 0
|
Forced Expiratory volume will be measured with a spirometry test. |
Day 0
|
|
Forced Expiratory volume (L)
Časové okno: Month 6
|
Forced Expiratory volume will be measured with a spirometry test. |
Month 6
|
|
Forced Expiratory volume (L)
Časové okno: Year 1
|
Forced Expiratory volume will be measured with a spirometry test. |
Year 1
|
|
Forced Expiratory volume (L)
Časové okno: Year 2
|
Forced Expiratory volume will be measured with a spirometry test. |
Year 2
|
|
Forced Expiratory volume (L)
Časové okno: Year 5
|
Forced Expiratory volume will be measured with a spirometry test. |
Year 5
|
|
Tiffeneau ratio (%).
Časové okno: Day 0
|
Tiffeneau ratio will be calculated by dividing the Forced Expiratory volume to the Forced vital Capacity. |
Day 0
|
|
Tiffeneau ratio (%).
Časové okno: Month 6
|
Tiffeneau ratio will be calculated by dividing the Forced Expiratory volume to the Forced vital Capacity. |
Month 6
|
|
Tiffeneau ratio (%).
Časové okno: Year 1
|
Tiffeneau ratio will be calculated by dividing the Forced Expiratory volume to the Forced vital Capacity. |
Year 1
|
|
Tiffeneau ratio (%).
Časové okno: Year 2
|
Tiffeneau ratio will be calculated by dividing the Forced Expiratory volume to the Forced vital Capacity. |
Year 2
|
|
Tiffeneau ratio (%).
Časové okno: Year 5
|
Tiffeneau ratio will be calculated by dividing the Forced Expiratory volume to the Forced vital Capacity. |
Year 5
|
|
Ventilatory reserve (%).
Časové okno: Day 0
|
Ventilatory reserve will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer. |
Day 0
|
|
Ventilatory reserve (%).
Časové okno: Month 6
|
Ventilatory reserve will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer. |
Month 6
|
|
Ventilatory reserve (%).
Časové okno: Year 1
|
Ventilatory reserve will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer. |
Year 1
|
|
Ventilatory reserve (%).
Časové okno: Year 2
|
Ventilatory reserve will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer. |
Year 2
|
|
Ventilatory reserve (%).
Časové okno: Year 5
|
Ventilatory reserve will be obtained by performing a cardiopulmonary exercise testing at maximal effort during incremental exercise on a cycle ergometer. |
Year 5
|
|
Physical activity
Časové okno: Day 0
|
Physical activity will be measured using the Global Physical Activity Questionnaire (GPAQ) |
Day 0
|
|
Physical activity
Časové okno: Month 6
|
Physical activity will be measured using the Global Physical Activity Questionnaire (GPAQ) |
Month 6
|
|
Physical activity
Časové okno: Year 1
|
Physical activity will be measured using the Global Physical Activity Questionnaire (GPAQ) |
Year 1
|
|
Physical activity
Časové okno: Year 2
|
Physical activity will be measured using the Global Physical Activity Questionnaire (GPAQ) |
Year 2
|
|
Physical activity
Časové okno: Year 5
|
Physical activity will be measured using the Global Physical Activity Questionnaire (GPAQ) |
Year 5
|
|
Functional capacity timed-up and go
Časové okno: Day 0
|
Functional capacity will be evaluated using the Timed-Up and Go test. |
Day 0
|
|
Functional capacity timed-up and go
Časové okno: Month 6
|
Functional capacity will be evaluated using the Timed-Up and Go test. |
Month 6
|
|
Functional capacity timed-up and go
Časové okno: Year 1
|
Functional capacity will be evaluated using the Timed-Up and Go test. |
Year 1
|
|
Functional capacity timed-up and go
Časové okno: Year 2
|
Functional capacity will be evaluated using the Timed-Up and Go test. |
Year 2
|
|
Functional capacity timed-up and go
Časové okno: Year 5
|
Functional capacity will be evaluated using the Timed-Up and Go test. |
Year 5
|
|
Functional capacity TDM6
Časové okno: Day 0
|
Functional capacity will be evaluated using the 6-minute walk test. |
Day 0
|
|
Functional capacity TDM6
Časové okno: Month 6
|
Functional capacity will be evaluated using the 6-minute walk test. |
Month 6
|
|
Functional capacity TDM6
Časové okno: Year 1
|
Functional capacity will be evaluated using the 6-minute walk test. |
Year 1
|
|
Functional capacity TDM6
Časové okno: Year 2
|
Functional capacity will be evaluated using the 6-minute walk test. |
Year 2
|
|
Functional capacity TDM6
Časové okno: Year 5
|
Functional capacity will be evaluated using the 6-minute walk test. |
Year 5
|
|
Functional capacity Five Times Sit to Stand test.
Časové okno: Day 0
|
Functional capacity will be evaluated using the Five Times Sit to Stand test. |
Day 0
|
|
Functional capacity Five Times Sit to Stand test.
Časové okno: Month 6
|
Functional capacity will be evaluated using the Five Times Sit to Stand test. |
Month 6
|
|
Functional capacity Five Times Sit to Stand test.
Časové okno: Year 1
|
Functional capacity will be evaluated using the Five Times Sit to Stand test. |
Year 1
|
|
Functional capacity Five Times Sit to Stand test.
Časové okno: Year 2
|
Functional capacity will be evaluated using the Five Times Sit to Stand test. |
Year 2
|
|
Functional capacity Five Times Sit to Stand test.
Časové okno: Year 5
|
Functional capacity will be evaluated using the Five Times Sit to Stand test. |
Year 5
|
|
Functional capacity SPPB
Časové okno: Day 0
|
Functional capacity will be evaluated using the Five Times Sit to Stand test.Functional capacity will be evaluated using the Short Physical Performance Battery test. |
Day 0
|
|
Functional capacity SPPB
Časové okno: Month 6
|
Functional capacity will be evaluated using the Five Times Sit to Stand test.Functional capacity will be evaluated using the Short Physical Performance Battery test. |
Month 6
|
|
Functional capacity SPPB
Časové okno: Year 1
|
Functional capacity will be evaluated using the Five Times Sit to Stand test.Functional capacity will be evaluated using the Short Physical Performance Battery test. |
Year 1
|
|
Functional capacity SPPB
Časové okno: Year 2
|
Functional capacity will be evaluated using the Five Times Sit to Stand test.Functional capacity will be evaluated using the Short Physical Performance Battery test. |
Year 2
|
|
Functional capacity SPPB
Časové okno: Year 5
|
Functional capacity will be evaluated using the Five Times Sit to Stand test.Functional capacity will be evaluated using the Short Physical Performance Battery test. |
Year 5
|
|
Functional capacity the mini-BESTest.
Časové okno: Day 0
|
Functional capacity will be evaluated using the mini-BESTest. |
Day 0
|
|
Functional capacity the mini-BESTest.
Časové okno: Month 6
|
Functional capacity will be evaluated using the mini-BESTest. |
Month 6
|
|
Functional capacity the mini-BESTest.
Časové okno: Year 1
|
Functional capacity will be evaluated using the mini-BESTest. |
Year 1
|
|
Functional capacity the mini-BESTest.
Časové okno: Year 2
|
Functional capacity will be evaluated using the mini-BESTest. |
Year 2
|
|
Functional capacity the mini-BESTest.
Časové okno: Year 5
|
Functional capacity will be evaluated using the mini-BESTest. |
Year 5
|
|
Functional capacity Berg Balance Scale.
Časové okno: Day 0
|
Functional capacity will be evaluated using the Berg Balance Scale. |
Day 0
|
|
Functional capacity Berg Balance Scale.
Časové okno: Month 6
|
Functional capacity will be evaluated using the Berg Balance Scale. |
Month 6
|
|
Functional capacity Berg Balance Scale.
Časové okno: Year 1
|
Functional capacity will be evaluated using the Berg Balance Scale. |
Year 1
|
|
Functional capacity Berg Balance Scale.
Časové okno: Year 2
|
Functional capacity will be evaluated using the Berg Balance Scale. |
Year 2
|
|
Functional capacity Berg Balance Scale.
Časové okno: Year 5
|
Functional capacity will be evaluated using the Berg Balance Scale. |
Year 5
|
|
Functional capacity 10-meter walk test
Časové okno: Day 0
|
Functional capacity will be evaluated using the 10-meter walk test (at usual and maximal pace). |
Day 0
|
|
Functional capacity 10-meter walk test
Časové okno: Month 6
|
Functional capacity will be evaluated using the 10-meter walk test (at usual and maximal pace). |
Month 6
|
|
Functional capacity 10-meter walk test
Časové okno: Year 1
|
Functional capacity will be evaluated using the 10-meter walk test (at usual and maximal pace). |
Year 1
|
|
Functional capacity 10-meter walk test
Časové okno: Year 2
|
Functional capacity will be evaluated using the 10-meter walk test (at usual and maximal pace). |
Year 2
|
|
Functional capacity 10-meter walk test
Časové okno: Year 5
|
Functional capacity will be evaluated using the 10-meter walk test (at usual and maximal pace). |
Year 5
|
|
Dyspnea
Časové okno: Day 0
|
Dyspnea will be evaluated by a Numeric Rating scale ranging from 0 to 10. |
Day 0
|
|
Dyspnea
Časové okno: Month 6
|
Dyspnea will be evaluated by a Numeric Rating scale ranging from 0 to 10. |
Month 6
|
|
Dyspnea
Časové okno: Year 1
|
Dyspnea will be evaluated by a Numeric Rating scale ranging from 0 to 10. |
Year 1
|
|
Dyspnea
Časové okno: Year 2
|
Dyspnea will be evaluated by a Numeric Rating scale ranging from 0 to 10. |
Year 2
|
|
Dyspnea
Časové okno: Year 5
|
Dyspnea will be evaluated by a Numeric Rating scale ranging from 0 to 10. |
Year 5
|
|
Perceived exertion before, during and after effort
Časové okno: DAy 0
|
Perceived exertion will be evaluated by a Numeric Rating scale ranging from 0 to 10. |
DAy 0
|
|
Perceived exertion before, during and after effort
Časové okno: Month 6
|
Perceived exertion will be evaluated by a Numeric Rating scale ranging from 0 to 10. |
Month 6
|
|
Perceived exertion before, during and after effort
Časové okno: Year 1
|
Perceived exertion will be evaluated by a Numeric Rating scale ranging from 0 to 10. |
Year 1
|
|
Perceived exertion before, during and after effort
Časové okno: Year 2
|
Perceived exertion will be evaluated by a Numeric Rating scale ranging from 0 to 10. |
Year 2
|
|
Perceived exertion before, during and after effort
Časové okno: Year 5
|
Perceived exertion will be evaluated by a Numeric Rating scale ranging from 0 to 10. |
Year 5
|
|
Musculoskeletal Pain
Časové okno: Day 0
|
: Pain will be measured by a visual analogue scale (VAS) ranging from 0 to 10 and possibly as appropriate by other questionnaires or specific scales. |
Day 0
|
|
Musculoskeletal Pain
Časové okno: Month 6
|
: Pain will be measured by a visual analogue scale (VAS) ranging from 0 to 10 and possibly as appropriate by other questionnaires or specific scales. |
Month 6
|
|
Musculoskeletal Pain
Časové okno: Year 1
|
: Pain will be measured by a visual analogue scale (VAS) ranging from 0 to 10 and possibly as appropriate by other questionnaires or specific scales. |
Year 1
|
|
Musculoskeletal Pain
Časové okno: Year 2
|
: Pain will be measured by a visual analogue scale (VAS) ranging from 0 to 10 and possibly as appropriate by other questionnaires or specific scales. |
Year 2
|
|
Musculoskeletal Pain
Časové okno: Year 5
|
: Pain will be measured by a visual analogue scale (VAS) ranging from 0 to 10 and possibly as appropriate by other questionnaires or specific scales. |
Year 5
|
|
Sarcopenia risk
Časové okno: Day 0
|
Sarcopenia risk will be evaluated with the SARC-F Questionnaire. |
Day 0
|
|
Sarcopenia risk
Časové okno: Month 6
|
Sarcopenia risk will be evaluated with the SARC-F Questionnaire. |
Month 6
|
|
Sarcopenia risk
Časové okno: Year 1
|
Sarcopenia risk will be evaluated with the SARC-F Questionnaire. |
Year 1
|
|
Sarcopenia risk
Časové okno: Year 2
|
Sarcopenia risk will be evaluated with the SARC-F Questionnaire. |
Year 2
|
|
Sarcopenia risk
Časové okno: Year 5
|
Sarcopenia risk will be evaluated with the SARC-F Questionnaire. |
Year 5
|
|
Social insecurity
Časové okno: Day 0
|
Social insecurity will be evaluated with the EPICES Score Questionnaire. |
Day 0
|
|
Social insecurity
Časové okno: Month 6
|
Social insecurity will be evaluated with the EPICES Score Questionnaire. |
Month 6
|
|
Social insecurity
Časové okno: Year 1
|
Social insecurity will be evaluated with the EPICES Score Questionnaire. |
Year 1
|
|
Social insecurity
Časové okno: Year 2
|
Social insecurity will be evaluated with the EPICES Score Questionnaire. |
Year 2
|
|
Social insecurity
Časové okno: Year 5
|
Social insecurity will be evaluated with the EPICES Score Questionnaire. |
Year 5
|
|
Kinesiophobia
Časové okno: Day 0
|
Kinesiophobia will be evaluated with the TAMPA Scale. |
Day 0
|
|
Kinesiophobia
Časové okno: Month 6
|
Kinesiophobia will be evaluated with the TAMPA Scale. |
Month 6
|
|
Kinesiophobia
Časové okno: Year 1
|
Kinesiophobia will be evaluated with the TAMPA Scale. |
Year 1
|
|
Kinesiophobia
Časové okno: Year 2
|
Kinesiophobia will be evaluated with the TAMPA Scale. |
Year 2
|
|
Kinesiophobia
Časové okno: Year 5
|
Kinesiophobia will be evaluated with the TAMPA Scale. |
Year 5
|
|
Quality of life
Časové okno: Day 0
|
Quality of life will be evaluated with the 36-Item Short Form Survey. |
Day 0
|
|
Quality of life
Časové okno: Month 6
|
Quality of life will be evaluated with the 36-Item Short Form Survey. |
Month 6
|
|
Quality of life
Časové okno: Year 1
|
Quality of life will be evaluated with the 36-Item Short Form Survey. |
Year 1
|
|
Quality of life
Časové okno: Year 2
|
Quality of life will be evaluated with the 36-Item Short Form Survey. |
Year 2
|
|
Quality of life
Časové okno: Year 5
|
Quality of life will be evaluated with the 36-Item Short Form Survey. |
Year 5
|
|
: Balance confidence in performing various activities
Časové okno: Day 0
|
Self-report balance confidence will be evaluated with the Activities-specific Balance Confidence (ABC) Scale.vey. |
Day 0
|
|
: Balance confidence in performing various activities
Časové okno: Month 6
|
Self-report balance confidence will be evaluated with the Activities-specific Balance Confidence (ABC) Scale.vey. |
Month 6
|
|
: Balance confidence in performing various activities
Časové okno: Year 1
|
Self-report balance confidence will be evaluated with the Activities-specific Balance Confidence (ABC) Scale.vey. |
Year 1
|
|
: Balance confidence in performing various activities
Časové okno: Year 2
|
Self-report balance confidence will be evaluated with the Activities-specific Balance Confidence (ABC) Scale.vey. |
Year 2
|
|
: Balance confidence in performing various activities
Časové okno: Year 5
|
Self-report balance confidence will be evaluated with the Activities-specific Balance Confidence (ABC) Scale.vey. |
Year 5
|
|
Functioning in regards to activities of daily living.
Časové okno: Day 0
|
Functioning will be evaluated with the Lawton Instrumental Activities of Daily Living (IADL) Scale. |
Day 0
|
|
Functioning in regards to activities of daily living.
Časové okno: Month 6
|
Functioning will be evaluated with the Lawton Instrumental Activities of Daily Living (IADL) Scale. |
Month 6
|
|
Functioning in regards to activities of daily living.
Časové okno: Year 1
|
Functioning will be evaluated with the Lawton Instrumental Activities of Daily Living (IADL) Scale. |
Year 1
|
|
Functioning in regards to activities of daily living.
Časové okno: Year 2
|
Functioning will be evaluated with the Lawton Instrumental Activities of Daily Living (IADL) Scale. |
Year 2
|
|
Functioning in regards to activities of daily living.
Časové okno: Year 5
|
Functioning will be evaluated with the Lawton Instrumental Activities of Daily Living (IADL) Scale. |
Year 5
|
|
Exhaustion
Časové okno: Day 0
|
Exhaustion will be evaluated with the FACIT-F Questionnaire. |
Day 0
|
|
Exhaustion
Časové okno: Month 6
|
Exhaustion will be evaluated with the FACIT-F Questionnaire. |
Month 6
|
|
Exhaustion
Časové okno: Year 1
|
Exhaustion will be evaluated with the FACIT-F Questionnaire. |
Year 1
|
|
Exhaustion
Časové okno: Year 2
|
Exhaustion will be evaluated with the FACIT-F Questionnaire. |
Year 2
|
|
Exhaustion
Časové okno: Year 5
|
Exhaustion will be evaluated with the FACIT-F Questionnaire. |
Year 5
|
|
Patient's opinion about their knee and associated problems
Časové okno: Day 0
|
: Outcomes will be evaluated with the Knee Injury and Osteoarthritis Outcome Score (KOOS). |
Day 0
|
|
Patient's opinion about their knee and associated problems
Časové okno: Month 6
|
: Outcomes will be evaluated with the Knee Injury and Osteoarthritis Outcome Score (KOOS). |
Month 6
|
|
Patient's opinion about their knee and associated problems
Časové okno: Year 1
|
: Outcomes will be evaluated with the Knee Injury and Osteoarthritis Outcome Score (KOOS). |
Year 1
|
|
Patient's opinion about their knee and associated problems
Časové okno: Year 2
|
: Outcomes will be evaluated with the Knee Injury and Osteoarthritis Outcome Score (KOOS). |
Year 2
|
|
Patient's opinion about their knee and associated problems
Časové okno: Year 5
|
: Outcomes will be evaluated with the Knee Injury and Osteoarthritis Outcome Score (KOOS). |
Year 5
|
|
Patient's opinion about their hip and associated problems
Časové okno: Day 0
|
Outcomes will be evaluated with the Hip Injury and Osteoarthritis Outcome Score (HOOS). |
Day 0
|
|
Patient's opinion about their hip and associated problems
Časové okno: Month 6
|
Outcomes will be evaluated with the Hip Injury and Osteoarthritis Outcome Score (HOOS). |
Month 6
|
|
Patient's opinion about their hip and associated problems
Časové okno: Year 1
|
Outcomes will be evaluated with the Hip Injury and Osteoarthritis Outcome Score (HOOS). |
Year 1
|
|
Patient's opinion about their hip and associated problems
Časové okno: Year 2
|
Outcomes will be evaluated with the Hip Injury and Osteoarthritis Outcome Score (HOOS). |
Year 2
|
|
Patient's opinion about their hip and associated problems
Časové okno: Year 5
|
Outcomes will be evaluated with the Hip Injury and Osteoarthritis Outcome Score (HOOS). |
Year 5
|
|
Predicting discharge destination after total joint arthroplasty.
Časové okno: Day 0
|
: Discharge destination will be evaluated with the Risk Assessment and Prediction Tool (RAPT); |
Day 0
|
|
Predicting discharge destination after total joint arthroplasty.
Časové okno: Month 6
|
: Discharge destination will be evaluated with the Risk Assessment and Prediction Tool (RAPT); |
Month 6
|
|
Physical function in myositis patients
Časové okno: Day 0
|
Physical function will be evaluated with the Stanford Health Assessment Questionnaire. |
Day 0
|
|
Physical function in myositis patients
Časové okno: Month 6
|
Physical function will be evaluated with the Stanford Health Assessment Questionnaire. |
Month 6
|
|
Physical function in myositis patients
Časové okno: Year 1
|
Physical function will be evaluated with the Stanford Health Assessment Questionnaire. |
Year 1
|
|
Physical function in myositis patients
Časové okno: Year 2
|
Physical function will be evaluated with the Stanford Health Assessment Questionnaire. |
Year 2
|
|
Physical function in myositis patients
Časové okno: Year 5
|
Physical function will be evaluated with the Stanford Health Assessment Questionnaire. |
Year 5
|
|
Quality of life in Parkinson's Disease
Časové okno: Day 0
|
Quality of life will be measured with the Parkinson's Disease Questionnaire-39 (PDQ-39). |
Day 0
|
|
Quality of life in Parkinson's Disease
Časové okno: Month 6
|
Quality of life will be measured with the Parkinson's Disease Questionnaire-39 (PDQ-39). |
Month 6
|
|
Quality of life in Parkinson's Disease
Časové okno: Year 1
|
Quality of life will be measured with the Parkinson's Disease Questionnaire-39 (PDQ-39). |
Year 1
|
|
Quality of life in Parkinson's Disease
Časové okno: Year 2
|
Quality of life will be measured with the Parkinson's Disease Questionnaire-39 (PDQ-39). |
Year 2
|
|
Quality of life in Parkinson's Disease
Časové okno: Year 5
|
Quality of life will be measured with the Parkinson's Disease Questionnaire-39 (PDQ-39). |
Year 5
|
|
Actimetry.
Časové okno: during 5 consecutive days after day 0
|
Actimetry data (energy expenditure, number of steps, sedentary time, total physical activity, etc.) will be obtained with the WGT3X-BT Actigraph inertial sensor unit. |
during 5 consecutive days after day 0
|
|
Title: Muscle Cross-Sectional Area (CSA) of the quadriceps muscles (cm^2)
Časové okno: Day 0
|
Cross-sectional area of the quadriceps muscles will be measured by conventional B-mode ultrasound using the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Day 0
|
|
Title: Muscle Cross-Sectional Area (CSA) of the quadriceps muscles (cm^2)
Časové okno: Month 6
|
Cross-sectional area of the quadriceps muscles will be measured by conventional B-mode ultrasound using the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Month 6
|
|
Title: Muscle Cross-Sectional Area (CSA) of the quadriceps muscles (cm^2)
Časové okno: Year 1
|
Cross-sectional area of the quadriceps muscles will be measured by conventional B-mode ultrasound using the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Year 1
|
|
Title: Muscle Cross-Sectional Area (CSA) of the quadriceps muscles (cm^2)
Časové okno: Year 2
|
Cross-sectional area of the quadriceps muscles will be measured by conventional B-mode ultrasound using the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Year 2
|
|
Title: Muscle Cross-Sectional Area (CSA) of the quadriceps muscles (cm^2)
Časové okno: Year 5
|
Cross-sectional area of the quadriceps muscles will be measured by conventional B-mode ultrasound using the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Year 5
|
|
Subcutaneous Adipose Tissue Thickness Over the Quadriceps (mm)
Časové okno: Day 0
|
Thickness of the subcutaneous adipose tissue overlying the quadriceps muscles will be measured by conventional B-mode ultrasound using the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Day 0
|
|
Subcutaneous Adipose Tissue Thickness Over the Quadriceps (mm)
Časové okno: Month 6
|
Thickness of the subcutaneous adipose tissue overlying the quadriceps muscles will be measured by conventional B-mode ultrasound using the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Month 6
|
|
Subcutaneous Adipose Tissue Thickness Over the Quadriceps (mm)
Časové okno: Year 1
|
Thickness of the subcutaneous adipose tissue overlying the quadriceps muscles will be measured by conventional B-mode ultrasound using the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Year 1
|
|
Subcutaneous Adipose Tissue Thickness Over the Quadriceps (mm)
Časové okno: Year 2
|
Thickness of the subcutaneous adipose tissue overlying the quadriceps muscles will be measured by conventional B-mode ultrasound using the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Year 2
|
|
Subcutaneous Adipose Tissue Thickness Over the Quadriceps (mm)
Časové okno: Year 5
|
Thickness of the subcutaneous adipose tissue overlying the quadriceps muscles will be measured by conventional B-mode ultrasound using the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Year 5
|
|
Muscle Cross-Sectional Area (CSA) of the Medial Gastrocnemius (cm^2)
Časové okno: Day 0
|
Cross-sectional area of the medial gastrocnemius muscle will be measured by conventional B-mode ultrasound using the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Day 0
|
|
Muscle Cross-Sectional Area (CSA) of the Medial Gastrocnemius (cm^2)
Časové okno: Month 6
|
Cross-sectional area of the medial gastrocnemius muscle will be measured by conventional B-mode ultrasound using the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Month 6
|
|
Muscle Cross-Sectional Area (CSA) of the Medial Gastrocnemius (cm^2)
Časové okno: Year 1
|
Cross-sectional area of the medial gastrocnemius muscle will be measured by conventional B-mode ultrasound using the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Year 1
|
|
Muscle Cross-Sectional Area (CSA) of the Medial Gastrocnemius (cm^2)
Časové okno: Year 2
|
Cross-sectional area of the medial gastrocnemius muscle will be measured by conventional B-mode ultrasound using the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Year 2
|
|
Muscle Cross-Sectional Area (CSA) of the Medial Gastrocnemius (cm^2)
Časové okno: Year 5
|
Cross-sectional area of the medial gastrocnemius muscle will be measured by conventional B-mode ultrasound using the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Year 5
|
|
Muscle Cross-Sectional Area (CSA) of the Lateral Gastrocnemius (cm^2)
Časové okno: Day 0
|
Cross-sectional area of the lateral gastrocnemius muscle will be measured by conventional B-mode ultrasound using the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Day 0
|
|
Muscle Cross-Sectional Area (CSA) of the Lateral Gastrocnemius (cm^2)
Časové okno: Month 6
|
Cross-sectional area of the lateral gastrocnemius muscle will be measured by conventional B-mode ultrasound using the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Month 6
|
|
Muscle Cross-Sectional Area (CSA) of the Lateral Gastrocnemius (cm^2)
Časové okno: Year 1
|
Cross-sectional area of the lateral gastrocnemius muscle will be measured by conventional B-mode ultrasound using the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Year 1
|
|
Muscle Cross-Sectional Area (CSA) of the Lateral Gastrocnemius (cm^2)
Časové okno: Year 2
|
Cross-sectional area of the lateral gastrocnemius muscle will be measured by conventional B-mode ultrasound using the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Year 2
|
|
Muscle Cross-Sectional Area (CSA) of the Lateral Gastrocnemius (cm^2)
Časové okno: Year 5
|
Cross-sectional area of the lateral gastrocnemius muscle will be measured by conventional B-mode ultrasound using the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Year 5
|
|
Quadriceps muscles Quality Assessed by Shear Wave Elastography (kPa or m/s)
Časové okno: Day 0
|
Muscle stiffness, reflecting muscle quality, will be assessed by Shear Wave Elastography (SWE) using the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Day 0
|
|
Quadriceps muscles Quality Assessed by Shear Wave Elastography (kPa or m/s)
Časové okno: Month 6
|
Muscle stiffness, reflecting muscle quality, will be assessed by Shear Wave Elastography (SWE) using the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Month 6
|
|
Quadriceps muscles Quality Assessed by Shear Wave Elastography (kPa or m/s)
Časové okno: Year 1
|
Muscle stiffness, reflecting muscle quality, will be assessed by Shear Wave Elastography (SWE) using the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Year 1
|
|
Quadriceps muscles Quality Assessed by Shear Wave Elastography (kPa or m/s)
Časové okno: Year 2
|
Muscle stiffness, reflecting muscle quality, will be assessed by Shear Wave Elastography (SWE) using the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Year 2
|
|
Quadriceps muscles Quality Assessed by Shear Wave Elastography (kPa or m/s)
Časové okno: Year 5
|
Muscle stiffness, reflecting muscle quality, will be assessed by Shear Wave Elastography (SWE) using the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Year 5
|
|
Medial Gastrocnemius Quality Assessed by Shear Wave Elastography (kPa or m/s)
Časové okno: Day 0
|
Muscle stiffness, reflecting muscle quality, will be assessed by Shear Wave Elastography (SWE) using the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Day 0
|
|
Medial Gastrocnemius Quality Assessed by Shear Wave Elastography (kPa or m/s)
Časové okno: Month 6
|
Muscle stiffness, reflecting muscle quality, will be assessed by Shear Wave Elastography (SWE) using the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Month 6
|
|
Medial Gastrocnemius Quality Assessed by Shear Wave Elastography (kPa or m/s)
Časové okno: Year 1
|
Muscle stiffness, reflecting muscle quality, will be assessed by Shear Wave Elastography (SWE) using the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Year 1
|
|
Medial Gastrocnemius Quality Assessed by Shear Wave Elastography (kPa or m/s)
Časové okno: Year 2
|
Muscle stiffness, reflecting muscle quality, will be assessed by Shear Wave Elastography (SWE) using the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Year 2
|
|
Medial Gastrocnemius Quality Assessed by Shear Wave Elastography (kPa or m/s)
Časové okno: Year 5
|
Muscle stiffness, reflecting muscle quality, will be assessed by Shear Wave Elastography (SWE) using the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Year 5
|
|
Lateral Gastrocnemius Quality Assessed by Shear Wave Elastography (kPa or m/s)
Časové okno: Day 0
|
Muscle stiffness, reflecting muscle quality, will be assessed by Shear Wave Elastography (SWE) using the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Day 0
|
|
Lateral Gastrocnemius Quality Assessed by Shear Wave Elastography (kPa or m/s)
Časové okno: Month 6
|
Muscle stiffness, reflecting muscle quality, will be assessed by Shear Wave Elastography (SWE) using the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Month 6
|
|
Lateral Gastrocnemius Quality Assessed by Shear Wave Elastography (kPa or m/s)
Časové okno: Year 1
|
Muscle stiffness, reflecting muscle quality, will be assessed by Shear Wave Elastography (SWE) using the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Year 1
|
|
Lateral Gastrocnemius Quality Assessed by Shear Wave Elastography (kPa or m/s)
Časové okno: Year 2
|
Muscle stiffness, reflecting muscle quality, will be assessed by Shear Wave Elastography (SWE) using the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Year 2
|
|
Lateral Gastrocnemius Quality Assessed by Shear Wave Elastography (kPa or m/s)
Časové okno: Year 5
|
Muscle stiffness, reflecting muscle quality, will be assessed by Shear Wave Elastography (SWE) using the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Year 5
|
|
Quadriceps muscles Microvascularization Assessed by Superb Microvascular Imaging (SMI) (%)
Časové okno: Day 0
|
Muscle microvascularization will be assessed using Superb Microvascular Imaging (SMI), a Doppler-based technique that detects very low-velocity blood flow without contrast agent injection, using the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Day 0
|
|
Quadriceps muscles Microvascularization Assessed by Superb Microvascular Imaging (SMI) (%)
Časové okno: Month 6
|
Muscle microvascularization will be assessed using Superb Microvascular Imaging (SMI), a Doppler-based technique that detects very low-velocity blood flow without contrast agent injection, using the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Month 6
|
|
Quadriceps muscles Microvascularization Assessed by Superb Microvascular Imaging (SMI) (%)
Časové okno: Year 1
|
Muscle microvascularization will be assessed using Superb Microvascular Imaging (SMI), a Doppler-based technique that detects very low-velocity blood flow without contrast agent injection, using the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Year 1
|
|
Quadriceps muscles Microvascularization Assessed by Superb Microvascular Imaging (SMI) (%)
Časové okno: Year 2
|
Muscle microvascularization will be assessed using Superb Microvascular Imaging (SMI), a Doppler-based technique that detects very low-velocity blood flow without contrast agent injection, using the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Year 2
|
|
Quadriceps muscles Microvascularization Assessed by Superb Microvascular Imaging (SMI) (%)
Časové okno: Year 5
|
Muscle microvascularization will be assessed using Superb Microvascular Imaging (SMI), a Doppler-based technique that detects very low-velocity blood flow without contrast agent injection, using the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Year 5
|
|
Medial Gastrocnemius Microvascularization Assessed by Superb Microvascular Imaging (SMI) (%)
Časové okno: Day 0
|
Muscle microvascularization will be assessed using Superb Microvascular Imaging (SMI), a Doppler-based technique that detects very low-velocity blood flow without contrast agent injection, using the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Day 0
|
|
Medial Gastrocnemius Microvascularization Assessed by Superb Microvascular Imaging (SMI) (%)
Časové okno: Month 6
|
Muscle microvascularization will be assessed using Superb Microvascular Imaging (SMI), a Doppler-based technique that detects very low-velocity blood flow without contrast agent injection, using the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Month 6
|
|
Medial Gastrocnemius Microvascularization Assessed by Superb Microvascular Imaging (SMI) (%)
Časové okno: Year 1
|
Muscle microvascularization will be assessed using Superb Microvascular Imaging (SMI), a Doppler-based technique that detects very low-velocity blood flow without contrast agent injection, using the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Year 1
|
|
Medial Gastrocnemius Microvascularization Assessed by Superb Microvascular Imaging (SMI) (%)
Časové okno: Year 2
|
Muscle microvascularization will be assessed using Superb Microvascular Imaging (SMI), a Doppler-based technique that detects very low-velocity blood flow without contrast agent injection, using the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Year 2
|
|
Medial Gastrocnemius Microvascularization Assessed by Superb Microvascular Imaging (SMI) (%)
Časové okno: Year 5
|
Muscle microvascularization will be assessed using Superb Microvascular Imaging (SMI), a Doppler-based technique that detects very low-velocity blood flow without contrast agent injection, using the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Year 5
|
|
Lateral Gastrocnemius Microvascularization Assessed by Superb Microvascular Imaging (SMI) (%)
Časové okno: Day 0
|
Muscle microvascularization will be assessed using Superb Microvascular Imaging (SMI), a Doppler-based technique that detects very low-velocity blood flow without contrast agent injection, using the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Day 0
|
|
Lateral Gastrocnemius Microvascularization Assessed by Superb Microvascular Imaging (SMI) (%)
Časové okno: Month 6
|
Muscle microvascularization will be assessed using Superb Microvascular Imaging (SMI), a Doppler-based technique that detects very low-velocity blood flow without contrast agent injection, using the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Month 6
|
|
Lateral Gastrocnemius Microvascularization Assessed by Superb Microvascular Imaging (SMI) (%)
Časové okno: Year 1
|
Muscle microvascularization will be assessed using Superb Microvascular Imaging (SMI), a Doppler-based technique that detects very low-velocity blood flow without contrast agent injection, using the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Year 1
|
|
Lateral Gastrocnemius Microvascularization Assessed by Superb Microvascular Imaging (SMI) (%)
Časové okno: Year 2
|
Muscle microvascularization will be assessed using Superb Microvascular Imaging (SMI), a Doppler-based technique that detects very low-velocity blood flow without contrast agent injection, using the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Year 2
|
|
Lateral Gastrocnemius Microvascularization Assessed by Superb Microvascular Imaging (SMI) (%)
Časové okno: Year 5
|
Muscle microvascularization will be assessed using Superb Microvascular Imaging (SMI), a Doppler-based technique that detects very low-velocity blood flow without contrast agent injection, using the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Year 5
|
|
Quadriceps muscles Blood Flow Velocity Measured by Doppler Ultrasound (cm/s)
Časové okno: Day 0
|
Muscle blood flow velocity will be measured using Doppler ultrasound with the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Day 0
|
|
Quadriceps muscles Blood Flow Velocity Measured by Doppler Ultrasound (cm/s)
Časové okno: Month 6
|
Muscle blood flow velocity will be measured using Doppler ultrasound with the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Month 6
|
|
Quadriceps muscles Blood Flow Velocity Measured by Doppler Ultrasound (cm/s)
Časové okno: Year 1
|
Muscle blood flow velocity will be measured using Doppler ultrasound with the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Year 1
|
|
Quadriceps muscles Blood Flow Velocity Measured by Doppler Ultrasound (cm/s)
Časové okno: Year 2
|
Muscle blood flow velocity will be measured using Doppler ultrasound with the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Year 2
|
|
Quadriceps muscles Blood Flow Velocity Measured by Doppler Ultrasound (cm/s)
Časové okno: Year 5
|
Muscle blood flow velocity will be measured using Doppler ultrasound with the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Year 5
|
|
Medial Gastrocnemius Blood Flow Velocity Measured by Doppler Ultrasound (cm/s)
Časové okno: Day 0
|
Muscle blood flow velocity will be measured using Doppler ultrasound with the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Day 0
|
|
Medial Gastrocnemius Blood Flow Velocity Measured by Doppler Ultrasound (cm/s)
Časové okno: Month 6
|
Muscle blood flow velocity will be measured using Doppler ultrasound with the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Month 6
|
|
Medial Gastrocnemius Blood Flow Velocity Measured by Doppler Ultrasound (cm/s)
Časové okno: Year 1
|
Muscle blood flow velocity will be measured using Doppler ultrasound with the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Year 1
|
|
Medial Gastrocnemius Blood Flow Velocity Measured by Doppler Ultrasound (cm/s)
Časové okno: Year 2
|
Muscle blood flow velocity will be measured using Doppler ultrasound with the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Year 2
|
|
Medial Gastrocnemius Blood Flow Velocity Measured by Doppler Ultrasound (cm/s)
Časové okno: Year 5
|
Muscle blood flow velocity will be measured using Doppler ultrasound with the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Year 5
|
|
Lateral Gastrocnemius Blood Flow Velocity Measured by Doppler Ultrasound (cm/s)
Časové okno: Day 0
|
Muscle blood flow velocity will be measured using Doppler ultrasound with the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Day 0
|
|
Lateral Gastrocnemius Blood Flow Velocity Measured by Doppler Ultrasound (cm/s)
Časové okno: Month 6
|
Muscle blood flow velocity will be measured using Doppler ultrasound with the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Month 6
|
|
Lateral Gastrocnemius Blood Flow Velocity Measured by Doppler Ultrasound (cm/s)
Časové okno: Year 1
|
Muscle blood flow velocity will be measured using Doppler ultrasound with the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Year 1
|
|
Lateral Gastrocnemius Blood Flow Velocity Measured by Doppler Ultrasound (cm/s)
Časové okno: Year 2
|
Muscle blood flow velocity will be measured using Doppler ultrasound with the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Year 2
|
|
Lateral Gastrocnemius Blood Flow Velocity Measured by Doppler Ultrasound (cm/s)
Časové okno: Year 5
|
Muscle blood flow velocity will be measured using Doppler ultrasound with the Canon Aplio a ultrasound system (Model CUS-AA000, Canon Medical Systems Corporation). |
Year 5
|
Spolupracovníci a vyšetřovatelé
Spolupracovníci
Vyšetřovatelé
- Vrchní vyšetřovatel: Frédéric Costes, University Hospital, Clermont-Ferrand
Termíny studijních záznamů
Hlavní termíny studia
Začátek studia (Aktuální)
Primární dokončení (Odhadovaný)
Dokončení studie (Odhadovaný)
Termíny zápisu do studia
První předloženo
První předloženo, které splnilo kritéria kontroly kvality
První zveřejněno (Aktuální)
Aktualizace studijních záznamů
Poslední zveřejněná aktualizace (Aktuální)
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
Naposledy ověřeno
Více informací
Termíny související s touto studií
Klíčová slova
Další relevantní podmínky MeSH
- Synukleinopatie
- Onemocnění mozku
- Onemocnění centrálního nervového systému
- Nemoci nervového systému
- Patologické procesy
- Poruchy výživy
- Atributy nemoci
- Nadměrná výživa
- Tělesná hmotnost
- Nemoci dýchacích cest
- Plicní onemocnění
- Plicní onemocnění, obstrukční
- Neurodegenerativní onemocnění
- Poruchy pohybu
- Nadváha
- Parkinsonské poruchy
- Bazální gangliové choroby
- Patologické stavy, příznaky a symptomy
- Nutriční a metabolické nemoci
- Příznaky a symptomy
- Obezita
- Plicní onemocnění, chronická obstrukční
- Parkinsonova choroba
- Chronické onemocnění
Další identifikační čísla studie
- RBHP 2019 COSTES
- 2019-A01017-50 (Jiný identifikátor: 2019-A01017-50)
Informace o lécích a zařízeních, studijní dokumenty
Studuje lékový produkt regulovaný americkým FDA
Studuje produkt zařízení regulovaný americkým úřadem FDA
Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .